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Individuals Who Go Beyond 
Clinical Responsibilities 
To the Editor: 
Thank you for the article on Michael Saulino PM'97 and the NIH trial on 
Body Weight Support Training in the December 1999 issue. The coverage of 
our center and its research is important information to share with the Jefferson 
family, but just as importantly, serves to reinforce the commitment of those 
individuals who go beyond clinical responsibilities and contribute to new 
knowledge. Such individuals are crucial to an academic medical center. 
John F. Ditunno Jr., M.D. 
Professor of Rehabilitation Medicine 
Project Director of the Regional Spinal Cord Injury Center 
of the Delaware Valley, Thomas Jefferson University 
The Heimlich Maneuver 
To the Editor: 
Of great interest was the biographical material you have published on Samuel D. 
Gross '1828 and Chevalier Jackson '1886. Both of these gentlemen greatly 
contributed to the knowledge leading me to develop the Heimlich maneuver to 
save choking victims. It was Gross's book, published in 1854, as well as studies 
by Jackson and his associates, that proved backslaps drive choking objects 
deeper or tighter into the airway, causing death. 
We just celebrated the 25th anniversary of the Heimlich maneuver, first 
described in 1974. I see that Gross first taught surgery at the Medical College of 
Ohio, later known as the Medical Department of Cincinnati College, from 1833 
to 1840. I was an Associate Clinical Professor of Surgery for several years at the 
University of Cincinnati. We seem to be following each other around. 
Henry J. Heimlich, M.D., Sc.D. 
President, The Heimlich Institute, Cincinnati 
Upcoming Events 
March 1, Wednesday 
Alumni reception with Dean and Senior Vice President for Academic Affairs 
Joseph S. Gonnella, M.D. at the PGA National Resort, Palm Beach Gardens, FL 
March 2, Thursday 
Alumni reception with Dr. Gonnella at the Hyatt Regency Coral Gables at 
the Alhambra, in Coral Gables, FL 
March 16, Thursday 
Center for Integrative Medicine event with Andrew Weil, M.D. at the 
Park Hyatt Philadelphia at the Bellevue 
March 23, Thursday 
Alumni Executive Committee meeting 
April 7, Friday, 8:00 P.M., First Baptist Church, 17th and Sansom Streets 
Thomas Jefferson University Choir and Orchestra directed by Robert T. Sataloff 
M.D.'75, D.M.A. (program will feature Mozart's Requiem) 
April 13, Thursday 
Alumni reception at the meeting of the American College of Physicians, 
Philadelphia (Eakins Lounge at Jefferson) 
April 15, Saturday 
TJUH Women's Board Jefferson Ball at the Park Hyatt at the Bellevue 
April 27, Thursday 
Alumni annual business meeting (see page 22) 
April 30, Sunday 
An afternoon of song with Peter Nero, Stuart Neill, and Tonia Tecce, benefiting 
Jefferson's gastroenterology program, at the Park Hyatt Philadelphia at the 
Bellevue 
May 15, Monday 
Alumni reception with Dean and Senior Vice President for Academic Affairs 
Joseph S. Gonnella, M.D., at the Stanford Inn, Palo Alto, CA 
May 16, Tuesday 
Alumni reception with Dr. Gonnella at the Sacramento Capital Club, 
Sacramento, CA 
May 17, Wednesday 
Alumni reception with Dr. Gonnella in San Francisco 
see Upcoming Events continued on page 31 
Lectures on Campus 
March 27, Monday, 4:00 P.M., Solis-Cohen Auditorium, 1020 Locust Street: 
Potter Lecture: Elaine Fuchs, Ph.D., Amgen Professor of Basic Sciences, 
University of Chicago, will speak on "Beauty is Skin Deep: Mechanisms of 
Growth and Differentiation in the Skin" 
April 6, Thursday, 4:00 P.M., Connelly Conference Room, Bluemle Building, 
10th and Locust Streets: Luscombe Lecture: John Stanley, M.D., Chair of 
Dermatology at the University of Pennsylvania, will speak on "Pathophysiology 
of Pemphigus" 
April 25, Tuesday, 5:00 P.M., Solis-Cohen Auditorium, 1020 Locust Street: 
Hodes Lecture: Hedvig Hricak, M.D., Ph.D., Chair of Radiology, Memorial 
Sloan-Kettering Cancer Center, NY 
April 26, Wednesday, 10:30 A.M., DePalma Auditorium, 1025 Walnut Street: 
Biele Lecture: Charles F. Reynolds III, M.D., Professor, Psychiatry, Neurology, 
Neuroscience, and Senior Associate Dean, University of Pittsburgh School of 
Medicine, will speak on "Achieving and Maintaining Optimal Therapeutic 
Outcomes in Late Life Depression" 
April 27, Thursday, 5:00 P.M., DePalma Auditorium, 
1025 Walnut Street: Lang Lecture: Barbara F. Atkinson '74, 
Professor and Chair of Pathology and Laboratory 
Medicine, University of Kansas School of Medicine, 
will speak on "Board Certification in Maintenance of 
Competence" 
April 28, Friday, 9:00 A.M., Connelly Conference 
Room, Bluemle Building, 10th and Locust Streets: _ 
Brucker Lecture: speaker will be Joseph T. Sebastianelli, 
Executive Director, ScrippsCARE, California 
May 5, Friday, 5:00 P.M., DePalma Auditorium, 
1025 Walnut Street: Clerf Lecture: Herbert Kean OTO'60, 
Clinical Professor of Otolaryngology/Head and Neck 
Surgery at Jefferson, will speak on "Adventures in 
Rhinoplasty: 40 Years of Tremendous Progress" 
May 11, Thursday, 8:00 A.M., DePalma Auditorium, 1025 Walnut Street: 
Grandon Health Policy Lecture: Francesco Taroni, M.D., Director, Agenzia per i 
Servizi Sanitari Regionali, Rome, Italy will speak on "Through the Patient's Eyes: 
Whatever Happened to Trust?" 
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Integrative Medicine: Open to a Wider World 
Jefferson's New Center Broadens the Medical Mainstream 
Wh
ile the tribes of northern 
Europe fought each other 
with crude axes 2000 years ago, 
doctors in China inserted thin 
needles into the nerve centers of their 
patients to relieve symptoms ranging 
from arthritic pain and back pain to 
disturbances of the lower bowel. 
For much of this century, the medical 
profession in America has viewed 
"alternative" therapies like acupunc-
ture as unproven and unscientific, as 
remnants of superstition rather than 
legitimate avenues of treatment. 	 Rosenzweig 
The last decade, however, has witnessed a dramatic reversal of opinion. It has 
become clear that A) with or without their doctors' approval, vast numbers of 
Americans make use of nonallopathic techniques, and B) though often more 
difficult to submit to rigorous scientific scrutiny, many alternative 
therapies, once examined, prove to have legitimate healing value. 
Jefferson has greeted this groundswell with guarded enthusiasm, 
culminating with the formation in September 1998 of the Center for 
Integrative Medicine—the only one of its kind in the Delaware Valley. 
What exactly does "integrative medicine" encompass? Steven Rosenzweig 
EM'89, the center's director and a Clinical Associate Professor of 
Emergency Medicine, explains it from both historical and contemporary 
vantage points: "We look back to a term called 'alternative medicine' 
which implied a dichotomy, a split between conventional biomedicine 
and something else. Over the years the term 'complementary medicine' 
emerged—it was first popularized in the United Kingdom to imply the 
fact that certain therapies can complement and enhance standard care. 
"'Integrative medicine' implies that patients and providers can work 
together to combine high quality, conventional care with complementary 
approaches that are rational and safe. It's a comprehensive approach." 
Professional blinders to the depth of patient involvement in alternative 
techniques were removed by an article on "Unconventional Medicine in 
the United States: Prevalence, Costs, and Patterns of Use" in The New 
England Journal of Medicine in 1993. Based on 1539 telephone interviews 
across the country, the authors determined that 34 percent of respon-
dents had used at least one of 16 unconventional therapies over the 
preceding year; that a subset of that group who saw providers (as 
opposed to self-treatment) for unconventional therapy averaged 19 visits 
during the year; that 72 percent of those using unconventional therapies 
did not inform their doctors about it; and that, extrapolating to the 
whole population, some 22 million Americans spent $13.7 billion 
annually on alternative therapies—$10.3 billion of it paid out of pocket. 
These unconventional therapies, the article noted, were used to treat 
back problems, anxiety, headaches, chronic pain, and cancer, as well as 
AIDS, gastrointestinal problems, 
chronic renal failure, and eating 
disorders. Relaxation techniques, 
chiropractic, and massage attained 
the highest use. 
A series of 1998 articles in The 
Journal of the American Medical 
Association confirmed and 
extended the earlier study, noting, 
among other findings, that many 
patients find alternative techniques 
a better fit with their value 
systems; that many physicians 
were now recommending 
alternative therapies; that patient use of alternative therapies had risen from 34 
percent to 42 percent (especially with herbal therapy, high dose vitamins, 
massage, and homeopathy), and that the amount spent on these therapies had 
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risen to $21.7 billion per year. Altogether, as a JAMA editorial noted, "it appears that complementary 
and alternative medicine has again 'come of age' in the United States," moving toward the ubiquitous 
place it had held in the 19th century. 
Prompted by Congress, the National Institutes of Health established the Office of Alternative Medicine 
in 1992, which was upgraded in 1998 to the National Center for Complementary and Alternative 
Medicine with a budget of $60 million annually to support research. And research, as those involved in 
Jefferson's center agree, is sine qua non for the evaluation of complementary techniques. 
The Jefferson center arose from an informal coalescing of like-minded physicians who met weekly at seven 
A.M., starting in 1994. "We came together," explains Rosenzweig, "to create a center of activity for the 
exploration of complementary therapies in a way that was congruent with the academic and clinical 
mission of Jefferson." Group members included George Brainard, Ph.D., Professor of Neurology and 
now associate academic director of the center; Joyce Frye, D.O., an Instructor in Obstetrics and 
Gynecology; John Randall, M.D., the Alumni Chair of Family Medicine; and Shimon Waldfogel, M.D., 
Professor of Psychiatry. 
riTheir first activity was to launch a seminar for sophomore medical students to provide an overview of 
alternative healing practices, stressing their philosophical foundations and examining the scientific 
evidence behind them. Rosenzweig says students bring "a high degree of interest and skepticism" to the 
very popular course. In recent years, Jefferson Medical College has added seminars, lectures, and a 
clinical elective for seniors. The 1998-99 school year included over 50 curricular hours of mostly 
elective material in integrative medicine. 
The first patient program, established in 1995, was a 30-hour stress reduction program that had been 
developed at the University of Massachusetts Medical Center, and was supported by a history of clinical 
data indicating that mindfulness meditation helps lower anxiety and depression scores. The results at 
Jefferson parallel those at Massachusetts, says Rosenzweig: "Using four different validating instruments, 
we consistently show improvement in psychological distress scores, pain scores, and somatization scores." 
It is instructive to see how members of the integrative medicine team came to their interest in comple-
mentary techniques. For Rosenzweig, it springs in part from his background in philosophy (a B.A. from 
Brandeis). Following his medical degree from the University of Pennsylvania, he took his residency in 
emergency medicine at Jefferson. Two years later, in 1991, he joined the faculty. In addition to 
emergency medicine, he's been involved in medical humanities on campus, leading seminars related to 
the philosophy of medicine, medical ethics, and the history and sociology of science. So it wasn't much 
of a stretch that in 1994, he began offering courses that examined issues in alternative healing systems. 
Brainard comes from a hard-boiled science background: "By training I'm a neuroscientist [with a Ph.D. 
in anatomy from the University of Texas]. Ninety percent of the work I've done has been straightforward 
empirical neuroscience research. However, anybody who's interested in the brain is also interested in 
behavior and, ultimately, the human mind. I've always been curious about the role of mind in healing 
the body and the influence of the body in turn on mind. If you look at how the NIH classifies the various 
forms of complementary and alternative medicine, one of the biggest topics is mind/body medicine." 
By contrast, Randall's interest arose from the spiritual side: "Probably the thing that most influenced my 
interest in integrative medicine was my undergraduate training at Princeton in the department of 
religion," where he studied Eastern faiths and varied spiritual traditions. "One issue frequently 
overlooked in Western medicine is exploration of the patients' spiritual base, and at what stage they are 
in their path. A major ingredient of recovery is the spiritual outlook. When the patient begins to 
visualize recovery, it helps him recover. We're very good technically in medicine, but we haven't paid as 
much attention as we should have to the spiritual realm." 
The Center for Integrative Medicine fuses the traditional triad of research, education, and patient care. 
Its first goal, says Brainard, is to undertake "an openminded review of the current evidence base for 
complementary therapies" and to foster "honest, straightforward, empirical studies" of otherwise 
unproven techniques. Its second goal is provide students and clinicians with better access to relevant 
Though they insist that "complementary" therapies be 
rigorously tested so as not to harm or mislead patients, 
many "traditional" allopathic doctors are looking at such 
therapies with an open mind. Notable among them is 
William Fair '60, the revered cancer surgeon who for years 
was the Baumritter/Ancell Chair of Urologic Oncology at 
Memorial Sloan-Kettering Cancer Center in New York. Dr. 
Fair knows from personal experience—which he has shared 
with The New Yorker and Dateline NBC. 
In 1994 Fair was himself diagnosed with a colon tumor. 
Worse, it had spread to the lymph nodes. After two surgeries 
and a year of chemotherapy, the remaining option was more 
radical surgery. Typical of Fair, he refused to give up and he 
kept on working. But he kept getting sicker, till his wife 
Mary Ann insisted that he try an "alternative" approach. 
Dr. Fair had never paid much attention to unconventional 
therapies, but now he started doing meditation and yoga, 
and he changed his diet. He researched traditional Chinese 
medicine, especially herbs. 
And he started feeling better. Even more convincing, CAT 
scans showed a shrinking of his tumor, an actual reversal of 
its previous progression. 
In a complete turnaround from his attitude earlier in his 
career, Fair decided against the radical surgery that was 
proposed, and against chemotherapy or radiation. But he 
deems this new tack to be rational and scientific: he 
evaluated his new therapies in the same way scientists 
would measure whether a conventional solution had a 
quantifiable effect. 
The fact is, he felt more energy than he had for years. He 
trekked in Patagonia and Alaska. He learned to scuba dive. 
He began lecturing widely about alternative medicine to 
educate others. "There are things that happen during cancer 
that are not fully covered by allopathic approaches," he says. 
Fair believes the experience has made him a better doctor. 
Now, when he sees a patient, he's concerned above all about 
the patient's quality of life rather than whether the body has 
been rid of every cancer cell. "I feel we need to change 
medicine," he says. 
"Even if I eventually die, these 'unconventional' therapies 
have lengthened my life and improved it." 
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The Herbal Tradition 
"A Practitioner's Guide to Herbal Medicine," a conference sponsored last year 
by Jefferson's Center for Integrative Medicine, provided an interesting window 
onto a complementary therapy which maintains a strong following in Europe. 
The German government, for example, several years ago undertook an 
extensive examination of the literature on herbalism in Germany and issued 
a federal report—the Commission E—which was translated into English only 
in 1998. 
The main speaker at the conference was Simon Mills, MA, FNIMH, 
MCPP—not a medical doctor, but an investigator into the chemical actions o 
herbs and their components. He is a faculty member at the University of 
Exeter in England and author of a new textbook on phytotherapy published by 
Churchill Livingstone. 
Mills noted that adverse reactions to herbal remedies run only about one 
percent, in part because of low doses, in part because herbal concoctions are 
not single compounds, but rather mixes and balances that have been refined 
over centuries of use. On the other hand, he warned, it is essential that 
patients and physicians alike be aware of possible interactions between herbal 
and allopathic prescriptions, since both contain biologically active compounds. 
Herbal medicine, he observed, surged in popularity in Britain 150 years ago 
when, in the course of a generation, the country changed from a primarily 
agricultural and rural society to a primarily industrial and urban one. 
Country people brought their herbs with them, and herbalists became a 
mainstay in newly developed cities such as Manchester. The advent of 
antibiotics in World War II superseded much of the herbal medicine, but the 
tradition lingers on and is reviving. 
Mills gave some examples of legitimate chemical bases of herbal action: 
TANNIN: I  boiling the bark of a broad-leafed tree releases an antiseptic, 
anti-inflammatory "jacket" that seals wounds 
WORMWOOD, HOPS, AND OTHER BITTERS: used as aperitifs, they act as 
appetite stimulants 
"HOT" HERBS SUCH AS CAYENNE PEPPER: aid in drug absorption and so 
may be useful for lowering drug dosages 
GARLIC AND GINGER: raw, they can be used to induce a mild (100 to 101 
degree) fever. 
In herbal tradition, diseases are classified as "hot" or "cold" depending on 
which temperature remedy is applied. Herbalists usually work with, rather 
than against, inflammation and fever, said Mills. 
Can Ginkgo Biloba Help Alzheimer's? 
A Clinical Trial Will Tell 
Jefferson is the only university hospital in the region conducting a new clinical 
trial of the effects of gingko biloba on patients with Alzheimer's disease. 
Ginkgo biloba, an herbal treatment reputed to help increase blood flow in 
the brain and improve concentration and memory, is being studied at the 
Alzheimer's Disease and Dementia Center to determine if it will benefit 
patients with mild to moderate symptoms. The one-year study will involve 30 
to 36 patients. 
About four million Americans have Alzheimer's, including half of the 
population over age 85. The disease claims more than 100,000 lives a year 
and is the fourth leading cause of adult deaths. 
Reflecting its interest in researching both allopathic and complementary 
therapies, the center is also conducting a study of the safety and effectiveness 
of a more mainstream drug, designed to prevent or delay the development of 
Alzheimer's in patients in early stages of the disease. 
data, and to promote greater understanding of the philosophical underpinnings 
of alternative healing strategies. Its third goal is to responsibly integrate 
promising complementary therapies within a comprehensive patient care model. 
Jefferson's center is the first in the region to embrace all these goals. 
In the autumn of 1998, the center opened its clinical practice, located on the 
Ford Road campus, with Ira Cantor, M.D. and Steven Halbert, M.D. as associate 
clinical directors. Research and education take place at the main campus. The 
center also offers conferences (see sidebar on herbal therapies) and professional 
development programs for physicians, nurses, and other providers. 
Center physicians extend the practice of standard medicine to include 
nutritional therapies and selected herbal and homeopathic medicines. Other 
providers at the center offer acupuncture, massage therapy, nutritional 
counseling, mindfulness meditation for stress and pain management, movement 
therapy, and yoga. Only those therapies are employed which have a high safety 
profile and have been shown to have at least limited efficacy. Health outcomes 
data are collected on all patients. 
rpte lack of evidence-based data for complementary therapies highlights the 
l central importance of research at the center, whose directors echo the 
statement of Phil Fontamarosa and George Lundberg in a 1998 JAMA editorial: 
"There is no alternative medicine. There is only scientifically proven, evidence-
based medicine supported by solid data, or unproven medicine for which 
scientific evidence is lacking." 
On the subject of controlled testing of alternative therapies, Rosenzweig 
explains, "What we confront is a level of evidence that is provocative, 
suggestive, that cannot be dismissed out of hand, but that has not been taken to 
the next step of being tested in definitive clinical trials." 
High quality clinical studies of alternative therapies may look different from 
conventional drug trials. Herbs, for instance, are complex compounds in which 
it is often impossible to isolate single, active chemical agents. Moreover, herbs 
have traditionally been prescribed in highly individualized combinations, 
designed to treat each patient's overall constitution, rather than as single agents 
treating isolated symptoms. Nevertheless, the current trend is to test 
standardized single-herb extracts on single clinical outcomes. Steve Herrine '90, 
Clinical Assistant Professor in gastroenterology, has tested the use of milk 
thistle in the treatment of inflammatory liver disease—primarily hepatitis 
C—but the tests so far are fairly inconclusive. 
In the realm of mind/body medicine, such as yoga and massage therapy, a 
placebo control may be difficult if not impossible to devise—you are either 
doing yoga or you aren't. As for acupuncture, it has been shown in placebo-
controlled double-blind studies that stimulation of single points on the body can 
reduce pain and nausea. However, acupuncture is not practiced by stimulation 
of single points; instead, the patient is treated through the stimulation of 
multiple points. A "sham needle" control has been developed in Germany; at 
Jefferson, the center has submitted a proposal to the NIH to test the perioper-
ative use of acupuncture in patients undergoing total knee arthroplasty using 
the sham needle approach. 
Rosenzweig notes that Europeans have maintained a strong tradition of 
integrating conventional medicine with therapies such as massage and herbal 
treatments. However, he adds that "Integrative medicine is well established in 
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the United States by patients, who increasingly combine complementary 
therapies with their conventional care. And there are many therapies that today 
we call alternative but were in fact mainstream in our own culture in the past: 
for instance echinacea, before the advent of sulfa antibiotics, was probably the 
highest selling pharmaceutical in the United States. Nevertheless, there's 
something about the professional culture of biomedicine that allowed these 
other approaches to drop away." 
Brainard is particularly encouraged by the rate of progress on campus: "Frankly, 
when we started our little initiative, I never thought we'd have this much 
established at our own institution by 1999. And I never thought the NIH would 
have established a whole center of its own for these types of projects." 
Randall believes that though the American medical establishment is rightly 
opposed to "charlatanism" and baseless claims, it is becoming ever more open to 
the value of alternative therapies that can be proven, scientifically, to work. 
"The people who are constantly seeing patients know what the patients are 
asking for. The reason Jefferson is particularly open to integrative medicine, is 
that most of our physicians are very patient-centered." 
In the future, look for the mainstream of medicine to include a wider diversity 
of currents. it 
An Acupuncture Patient's Own Words 
"A year ago I began acupuncture treatments for a chronically sore right 
shoulder. I had been diagnosed with arthritis (though the shoulder problem 
goes back 30 years and may have other components). 
"My acupuncturist is a Chinese doctor of medicine in private practice, whose 
native degree has been accepted in the U.S. He maintains an office modest to 
the point of self-effacement and [unlike typical Jefferson physicians] does not 
deal with insurers. 
"His chief method of diagnosis, beyond listening to my complaints, involved 
taking the pulse in first my right, then my left wrist. He diagnosed arthritis, 
neck problems, and, additionally, weak lungs (he's right: I had contracted 
pneumonia several times as a child). 
"For some months I had had great difficulty sleeping, mostly from the 
attendant knotting of my neck and upper back muscles. Ibuprofen had offered 
almost no relief. 
began the recommended six-week treatment of two visits a week, during 
which he placed up to 10 needles in my head, neck, shoulder, and inside elbo 
After four weeks, the change was astonishing. Though I still feel strains with 
certain motions (like throwing underhand), I sleep normally and suffer only 
minor distress. At our vacation home, I shoveled rocks and hacked small logs 
into manageable lengths with a bowsaw for hours, with only minimal regret. 
"Compulsively skeptical, I don't see myself as very suggestible. I don't think 
this relief was a placebo effect. While my results can be properly classified as 
anecdotal, they don't feel anecdotal! They feel comforting. 
"There's a stumbling block, of course, to controlled testing of acupuncture: the 
treatment depends largely on the competence of the administrator. The same 
dose of pills can be expected to produce the same effect in a patient regardless 
of who prescribes them. With acupuncture, I found that the doctor—for whom 
I have profound respect—was more 'on' some days than others. When he hit 
the nerve centers perfectly, I could feel a jolt run across the bottom of my 
shoulder blade with each insertion. After such treatments, virtually all pain 
and discomfort disappeared within two days." 
Orthopaedics continued from page 9 
Rheumatoid arthritis occurs in genetically susceptible individuals in whom an 
unknown environmental agent triggers an autoimmune response leading to the 
production of mediators, particularly cytokines, that drive the pathophysio-
logical process resulting in the clinical manifestations of this disease. Most 
recent treatment efforts have concentrated on modulating either T-lymphocyte 
response or the activities of various arthritogenic cytokines. Antibodies directed 
against lymphocyte antigens, such as CD4, have shown antiarthritic effects, and 
several have been tested in clinical trials. Most anticytokine strategies have 
centered on the suppression of interleukin-1 and tumor necrosis factor-alpha. A 
major drawback to these treatment approaches is that these antiarthritic agents 
are proteins and are almost impossible to deliver on a continuing basis as drugs, 
markedly limiting the physician's ability to deliver them to patients in a 
targeted, sustained fashion for an extended period of time. 
Herndon and colleagues at Massachusetts General Hospital and the University of 
Pittsburgh, believing that gene therapy can be developed as a biological drug 
delivery system, and thus can obviate the problems with antiarthritic proteins, 
have begun the first gene therapy trial for arthritis. For inclusion in this trial 
patients must have marked involvement of the small joints of the hand, must be 
scheduled for replacement of the second through fifth metacarpophalangeal 
joints of at least one hand, and must be scheduled for an operation on at least 
one other joint before the metacarpophalangeal joint replacement. This last 
criterion gives investigators the opportunity to obtain synovial tissue from the 
patient as a source of autologous synoviocytes. 
These cells are grown in vitro, and one-half of the cells are transduced with the 
MFG-1RAP vector (interleukin-1 receptor antagonist protein). Saline suspen-
sions of both the untransduced, autologous control cells and the cells expressing 
the interleukin-1 Ra transgene are injected into selected hand joints. At the time 
of the joint replacement operation, the synovial fluid, synovial tissue, and any 
residual articular cartilage are recovered and assayed for the presence and 
expression of the transgene, and for evidence of a local biological response. The 
objective of this initial gene therapy trial is not to assess clinical improvement in 
patients, but rather to assess the probability of using gene therapy as a biological 
drug delivery system. 
A nother area of research with important implications for orthopaedics is 
...t.i.ssue engineering in which living cells are manipulated, either through 
their extracellular environment or genetically, to develop biologic substitutes 
either for implantation in the body or to stimulate the remodeling of tissue. 
Proteins, cells, biodegradable polymers, and other materials can be manipulated 
to facilitate the regeneration of musculoskeletal tissue. Investigators now can 
regenerate bone using combinations of progenitor cells, growth factors, blood 
vessels, and matrices. Tissue engineering of cartilage and bone, using different 
supporting materials in conjunction with adhesive proteins, growth factors, and 
autologous stem cells, ultimately will move from the laboratory to the clinic. 
Recombinant bioactive molecules will likely be developed to replace present 
bone graft materials. A long range goal is the in vivo remodeling of human 
cartilage and bone. 
Currently, attempts to induce articular cartilage regeneration in osteoarthritic 
joints are based mainly on stimulating the intrinsic healing capacity of articular 
cartilage by such techniques as subchondral drilling, abrasion, and microfracture, 
often combined with continuous passive motion and pharmacological agents. 
article concludes on page 11 
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James D. Heckman '69, 
the 1998-99 President of 
the American Academy 
of Orthopaedic Surgeons, 
and now Editor-in-Chief 
of the Journal of Bone 
and Joint Surgery, 
predicts 
that "The 
movement 
away from 
mechanical 
treatments 
toward 
biological treatments... 
will probably have a 
greater impact on our 
discipline in the future 
than even total joint 
arthroplasty" (quoted in 
the AAOS Bulletin, 
which gave extensive 
coverage to the analysis 
by Caterson, Tuan, and 
Gartland detailed at 
right). 
Heckman 
Orthopaedics Circa 2013 
71-m-e Gene', 	 ,s of Jeff Orthopaedists Describe the Future 
Adapted from an article by Edward J. Caterson '03, Rocky S. Tuan, Ph.D., and John J. Gartland S'44 
In his 1983 American Orthopaedic Association presidential address entitled "Orthopaedics in 2013: A Prospection," 
In  Mankin, M.D. of Harvard Medical School explained why he believes that future advances in orthopaedics will 
be based in biology, specifically in the ability to alter its basic unit, the cell. He prophesied that discoveries in cell biology, 
immunology, and cytogenetics could have a profound effect on orthopaedics. However, since Mankin's erudite look at 
the future, the playing field has tilted in ways that could not have been appreciated in 1983. Cellular discoveries have 
indeed had a profound effect on many areas of medicine but, unfortunately, not much of an effect on orthopaedics as yet. 
A major portion of the available research money since 1983 has gone to investigate diseases with the greatest death toll, 
such as cancer, pushing cancer research forward so that it is now done mostly at the level of the gene, as Mankin 
predicted. Significant changes in the practice environment and in the health care delivery system, impossible to predict in 
1983, have had a dampening effect on the amount of orthopaedic research funded and performed. The total number of 
orthopaedic surgeons nationwide who are principal investigators or co-investigators for major research projects, or who 
have sustained research programs for longer than a decade, has dropped sharply since the 1970s. 
Advances in molecular and genetic research since 1983 have had little impact to date on orthopaedic practice. But this 
situation is about to change rapidly as the huge volume of new information about the roles of genes in normal 
development, developmental variation, aging, repair, susceptibility to disease, and in the cause and pathogenesis of 
musculoskeletal diseases begins to be appreciated clinically. Now that we are slightly over halfway to the year 2013, we 
can review some of the progress made in genetic research in musculoskeletal science since 1983 and gauge the progress 
made toward Mankin's vision of orthopaedics. 
T t should be possible in the near future to describe the complete sequence of genetic events in the normal development 
i of the axial skeleton and limbs. Genes may be underexpressed, abnormally expressed, or overexpressed. The 
interaction of many genes and proteins, as well as environmental factors, determine quantitative skeletal traits such 
as bone mass. 
To date, over 20 musculoskeletal diseases have been linked to specific genes or chromosomes. Included in this list are 
Duchenne muscular dystrophy, familial osteoarthritis, Gaucher disease, Marfan syndrome, and osteogenesis imperfecta. 
The clinical phenotypes of osteogenesis imperfecta range from a mild increase in fracture frequency to a lethal perinatal 
form which vary according to the chain of procollagen type one that is affected, and the type and location of the 
mutation. A complete analysis of the genes associated with osteogenesis imperfecta will make it possible to predict the 
phenotype that will result from each type of molecular defect. Treatment of osteogenesis imperfecta by gene therapy will 
be possible by replacing the defective gene with a properly working version. 
As many as 10 percent of all fractures in the 
United States result in delayed or impaired union. 
Mechanical and iatrogenic factors aside, it now 
appears that some individuals are genetically 
predisposed to a less than satisfactory result. 
Subtle genetic differences may explain why some 
patients are more predisposed to orthopaedic 
complications, and why some heal better than 
others. One example is the genes which encode 
growth factors that promote tissue regeneration, 
such as the bone morphogenetic proteins which 
are members of the TGF beta gene superfamily, a 
large family of secreted signaling molecules. 
Bone morphogenetic proteins are synthesized as 
large precursors consisting of a single peptide, a 
Dr. Tuan (center) with members of his lab: research fellows Anna Osyczka, Ph.D. and Ulrich 
!sloth, M.D.; Research Assistant Professor Keith Danielson, Ph.D.; and E.J. Caterson '03 
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Above: "E.J." Caterson, an M.D./Ph.D. combined degree candidate, in the lab 
with (at right) Rocky Tuan, Ph.D., Vice Chair and Director of Research in 
Orthopaedics, accompanied by John Gartland S'44, retired Chair of the 
Department. Dr. Tuan runs Jefferson's research and training program in cell 
and tissue engineering. Under his direction, the basic research in the 
Orthopaedic Surgery Department has garnered NIH support placing it in the 
top three in the country. 
"I've known I wanted to be in academic orthopaedics since high school, when 
I volunteered with a pediatric orthopaedist," E.J. says. "Ever since surgery the 
first day, when the femoral head was handed to me during a hip arthoplasty, the 
field has clicked for me." 
E.J. came to Jefferson Medical College in 1996, and the following summer 
traveled to Romania with Operation Smile, with which he has volunteered 
hundreds of hours. In Romania the team provided orthopaedic and craniofacial 
reconstructive surgery to underprivileged children. 
"Back at Jeff, during my second year I heard about the Ph.D. program in tissue 
engineering. It was as if a program had been created specifically for me. 
"We're in the midst of a groundswell of molecular knowledge that will 
completely change how orthopaedists practice," E.J. realizes. "Tissue engineering 
is a marriage of clinical medicine with molecular and developmental biology, 
plus material science engineering." 
To tackle all these disciplines, E.I. did his molecular biology training at Jefferson, 
and with the aid of a Whitaker Foundation fellowship completed biomechanical 
and biomaterial engineering coursework at Drexel University's graduate school. 
A Foerderer Fellowship from Jefferson allowed him to spend a summer in the 
orthopaedic trauma unit of the Royal Infirmary in Edinburgh. "Choosing 
where to study was one of several times when Dr. Gartland has been an 
important mentor for me," E.J. says. 
"My thesis at Jefferson under Rocky Tuan centers on the use of mesenchymal 
stem cells," he continues. "We've learned how to induce them to differentiate 
into tissues of the mesodermal lineage. In Rocky's laboratory we're inducing 
the stem cells to become cartilage—which of course has profound implications 
for orthopaedic interventions in the future. 
"The things we're discovering will be in the clinic five or six years from now. 
I know that to go into 
teaching orthopaedics, 
I've got to be on the 
crest of emerging 
concepts." 
An M.D./Ph.D. 
from Jefferson 
The M.D./Ph.D. track 
is geared toward highly 
motivated students 
who plan careers as 
biomedical scientists. 
Two preclinical years 
of medical school are followed by three or more years of graduate research 
leading to a doctoral dissertation, then the final two years of medical school 
clinical clerkships. 
While trainees are completing the first and second year medical school 
curriculum, exposure to basic research is encouraged through seminars. 
Candidates spend the summer after their first year, and sometimes after their 
second year, in rotations through at least two laboratories, in order to 
familiarize themselves with modern experimental approaches, and to get a 
taste of specific fields of investigation as potential sites for their dissertation 
research. Labs are categorized into nine areas: biochemistry and molecular 
biology, cell and tissue engineering, developmental biology and teratology, 
genetics, immunology, microbiology and molecular virology, molecular 
pharmacology and structural biology, pathology and cell biology, and 
physiology. 
The third through fifth years include graduate-level coursework, an original 
research project in the lab of a faculty preceptor, then writing and defending a 
doctoral thesis. During the graduate school phase, trainees maintain contact 
with clinical activities through programs in hospital departments. Upon 
completing their Ph.D. dissertation, they return to the final two years of the 
medical curriculum. 
prodomain, and a carboxy terminal region of 100 to 125 amino acids. Within 
the carboxy terminal region of most of these proteins are seven highly conserved 
cysteine residues important for correct folding of these dimeric molecules. As 
the carboxy terminal region of the protein is released from its precursor by 
proteolytic processing, dimerization occurs and the mature, active homodimeric 
or heterodimeric protein is secreted. One of the key functions of bone morpho-
genetic-like proteins is to induce formation of cartilage, bone, and the 
supporting tissues of the skeleton. The bone induced by these molecules seems 
to behave the same as normal bone. Clinical indications for using bone morpho- 
a 
	 genetic protein could include replacing bone lost by trauma or by surgical 
resection; accelerating fracture repair; and augmenting spine fusions. 
steoarthritis and rheumatoid arthritis are emerging as leading conditions 
for musculoskeletal genetic research. The Centers for Disease Control and 
Prevention reported that arthritis and other rheumatic conditions are the 
leading cause of disability in the United States, affecting 43 million persons and 
costing more than $65 billion annually in the 1990s. By 2013, these numbers 
will increase hugely as the population ages. An interdisciplinary team at 
Jefferson led by Sergio Jimenez, M.D., Director of Rheumatology, is supported 
by a four year $3.7 million grant from the National Institutes of Health to 
investigate the underlying genetic causes of osteoarthritis. They are building on 
their preliminary success in demonstrating that mutations of the COL2A-1 gene 
can cause familial osteoarthritis. 
continued on page 7, right column 
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Doctoring a Sickly System 
Medical mistakes are rampant. James Bagian '77 thinks they can be avoided. 
From an article by Joseph P. Shapiro in U.S. News and World Report, December 13, 1999 
Tim Bagian has investigated deadly mistakes before. Following the 1986 Challenger 
space shuttle explosion, the physician, engineer, and astronaut supervised the 
capsule's recovery from the ocean floor, after first diving 95 feet into the warm 
Atlantic Ocean waters to find the remains of his friends and fellow astronauts. Then 
he redesigned the shuttle, adding an escape hatch, pressure suits, and parachutes to 
prevent another such tragedy. But even with the drama and derring-do of that 
mission, he says, the most important challenge of his life came two years ago when he 
was asked to figure out why medical errors were killing so many patients in hospitals 
run by the Veterans Administration. 
It's not that the VA's 172 hospitals were more dangerous than others. Medical errors 
are a fact of the health care system, as a new survey from the Institute of Medicine, 
National Academy of Sciences made clear in December. That report, To Err Is Human, 
estimated that 44,000 to 98,000 Americans a year die from preventable 
mistakes—from drug mixups to inattentive treatment—made in hospitals by 
physicians, pharmacists, and other health care professionals. Even the lower figure 
ranks hospital errors as the nation's eighth most frequent killer, taking more lives 
than car crashes. 
Air-crash Model 
Unlike car accidents, however, these avoidable deaths have attracted relatively little 
national attention—and little broad-based effort by the health care system to prevent 
them. To "break this cycle of inaction," the IOM recommends creating a new federal 
center to monitor such deaths—much the same way airline crashes and workplace 
accidents are tallied and analyzed—and to promote public health policies that would 
prevent them. It also calls for mandatory reporting of all blunders that result in 
serious harm. Says William Richardson, President of the W. K. Kellogg Foundation 
and chair of the IOM report committee: "These stunningly high rates of medical errors 
are simply unacceptable in a medical system that promises first to 'do no harm.— 
The IOM is the medical research arm of the prestigious 
National Academy of Sciences, and its recommendations 
often lead to congressional action. But change will not 
come easily. Doctors fear that any system that scrutinizes 
and reports medical missteps will expose them to serious 
legal liability. Still, it was a sign of how grave the 
problem has become that groups representing doctors, 
pharmacists, and hospitals generally praised last 
week's report. 
Anyone looking for a model of what the IOM envisions 
could start with the VA. This year, it began instituting 
many of Bagian's reforms, ones that are almost identical 
to, the idealized system proposed by the headline-
grabbing IOM report. A new National Center for Patient 
Safety, headed by Bagian, tracks errors at VA hospitals 
and clinics and spreads the gospel of prevention. "The 
VA has done perhaps the most impressive work in the 
country so far," says Donald Berwick, Chief of the 
Institute for Healthcare Improvement and a member of 
the IOM panel. "And hiring an astronaut to head that 
system was brilliant," he says, noting that aviation is one 
of the few industries that routinely investigates its own 
death-causing errors. 
Indeed, Bagian frequently compares the investigation of medical errors and airplane 
crashes. "Aircraft investigation people don't come in and say, 'Whose fault is it?' " 
says Bagian, a lanky, hyper-energetic 47-year-old with ice blue eyes. "They say, 
`What happened?' " Still, Bagian had to convince doctors and hospital administrators 
that he was more interested in the system's failures than in individual screwups. 
"The best of physicians make stupid errors," says Kenneth Kizer, the visionary 
former head of the VA health system who hired Bagian and made safety a priority. 
But these mistakes, he says, usually have little to do with a doctor's competence: 
"Mistakes are so prevalent and inevitable because health care is so complex." 
Solutions, however, are often astoundingly simple. One of the first things the VA 
did, for example, was to move bottles of concentrated potassium chloride, an 
essential bodily electrolyte given intravenously to patients, off hospital floors and 
into the pharmacy. That easy step ensures that a nurse will not inadvertently inject 
the solution in its deadly, undiluted form. 
Physician Scrawl 
Drug mixups are one of the most frequent causes of harm. More than 7,000 
Americans a year die from avoidable medication errors—more deaths than from 
workplace accidents. Confusion results because different drugs often have similar 
names and because of physicians' notoriously sloppy handwriting. In October, in 
what is thought to be the first case of its kind, a Texas jury found a doctor liable for 
a fatal medication foulup that resulted from an illegible prescription. The 42-year-
old patient died after taking a dangerous dosage of Plendil, a drug for high blood 
pressure, instead of Isordil, a drug for his angina. 
The VA hospitals are making clever use of barcoding technology to avoid medication 
bungles. Prescriptions are typed into computers, not handwritten. And barcoded 
labels, attached to a patient's wrist and a nurse's charts, are scanned each time a 
patient gets a pill, to check against mistakes. The idea came from a nurse at the 
Topeka VA hospital who, returning a rental car one day, 
noticed the wireless scanner used to check in her car. 
The system will be in place in every VA hospital by 
June 2000. 
Although the VA system is becoming a model for quality 
improvement, there are things that make it peculiarly 
suited for change. It is a large, integrated system of 
inpatient hospitals, nursing homes, and outpatient 
clinics. That makes it easy to track the care given each 
patient and to absorb the costs of putting in new error 
prevention programs. Further, VA doctors don't need to 
purchase malpractice insurance because the government 
compensates patients harmed by VA physicians' 
negligence. 
Still, other hospitals are coming up with their own 
innovations. Doctors, says Bagian, will respond to hard 
numbers that show where they fall short and how they 
can improve. But the most daunting task of all, he 
concedes, will be to change the whole culture of 
medicine from responding to crises to preventing them 
in the first place. 
io 	 JEFFERSON Medical College Alumni Bulletin 	 March 2000 
Smullens Addresses U.S. Senate Regarding Medical Errors 
tanton N. Smullens '61, Chief Medical Officer of the Jefferson Health System, testified on patient safety in 
Li December before the U.S. Senate Appropriations Subcommittee on Labor, Health and Human Services, and 
Education. Smullens addressed problems cited by the much publicized report on medical errors that was released 
at the beginning of December by the Institute of Medicine, National Academy of Sciences (see article on facing 
page). Speaking on behalf of the American Hospital Association, Smullens pointed out that mandatory public 
reporting can prevent candid discussion of errors, which is necessary to prevent future mistakes. Reporting 
requirements, he stressed, shouldn't induce punishment for errors. 
There needs to be "a nonpunitive culture," he said, that allows for candid discussion of errors, their causes, and 
how to prevent them from recurring. "If we cannot discuss our mistakes, we cannot learn from them." Smullens 
also presented AHA's initiatives to improve medication safety. 
The hearing was the first official congressional response to the IOM report and drew a standing-room-only 
crowd. Among the others who testified was the immediate past President of the American Medical Association, 
Nancy Dickey, M.D. 4, 
Jeff Is Consumers' Choice 
When it comes to meeting the health care needs of patients, Philadelphia consumers say 
Thomas Jefferson University Hospital rises to the top. Jeff was given the 1999 Consumer Choice 
Award by the National Research Corporation for being an innovator and leader in health care in 
Philadelphia. 
NRC annually conducts a national study of nearly 170,000 households to learn from consumers 
which hospitals they prefer. This is the third year that Jefferson has received this honor. 
The hospital has major programs for heart disease, cancer treatment, high risk childbirth, 
genetics, radiology, orthopaedics, digestive diseases, as well as numerous other areas of 
medicine and surgery. 
Orthopaedics from page 7, right column 
Now it is possible to grow chondrocytes ex 
vivo and seed them onto a bioactive and 
biodegradable matrix which, when 
implanted, can promote in vivo regener-
ation. Polymer science is evolving so that 
polymers can be coupled with cells, injected 
in viscous form into a cartilage defect, and 
hardened in situ by exposure to light. In 
addition, polymers can be used in a specific 
growth factor delivery function. Treatment 
of damaged or diseased articular cartilage in 
the future will involve the implantation of 
tissues and cells that respond to local 
stimuli through growth and differentiation 
into mature chondrocytes. These will be 
able to produce extracellular matrix that 
will integrate into the surrounding tissue. 
Bone marrow contains a population of rare 
progenitor cells, called mesenchymal stem 
cells, which are capable of differentiating 
into bone, cartilage, tendon, and other 
connective tissues. These cells have been 
shown capable of generating bone in a 
significant osseous defect. Mesenchymal 
stem cells will probably prove a better bond 
substitute than either autologous bone 
grafts or growth factors such as 
recombinant bone morphogenetic proteins. 
Jefferson's orthopaedic research laboratory 
combines gene therapy and selective tissue 
regeneration with cellular tissue 
engineering. At present, mesenchymal stem 
cells can be induced to form bone, cartilage, 
hepatocytes, and fat. Soon they will be used 
to produce adult human bone and cartilage 
as whole joint replacement materials. 
A new breed of orthopaedists will be 
practicing by 2013. They will understand 
the molecular mechanisms underlying 
orthopaedic deformities and diseases, and 
will use molecular technology as treatment 
modalities. Because genetic workings are 
extraordinarily nuanced, the knowledge 
base for molecular orthopaedics in 2013 
will be built partly by orthopaedists and 
partly by investigators in other areas of 
biology. Given the exploding growth of 
genetic knowledge, it seems appropriate to 
upgrade Mankin's 1983 prophecy that 
"joints will live in 2013" from a possibility 
to a strong probability. 
Portions adapted by permission from the Jefferson Orthopaedic Journal 1999 
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THE IWO 
The profile head inside a circle is the logo of Thomas 
Jefferson University, which includes Jefferson Medical 
College, the College of Graduate Studies, and the 
College of Health Professions. This logo was developed 
two decades ago and continues to be used now. 
The I inside a dark circle is the logo of the Jefferson 
Health System, which was formed in 1995 and 
includes Thomas Jefferson University Hospital and 
other major institutions (see below). 
Therefore, the I inside a circle is used for Thomas 
Jefferson University Hospital, and the profile head is 
used for Thomas Jefferson University (the academic 
affiliate). 
Thomas 
Jefferson 
University 
erson 
Health System 
r'N ver the past decade the health care environment in the Philadelphia 
kJ metropolitan area has been volatile, replete with hospital mergers and 
acquisitions. To serve the needs of its community and to work effectively under 
managed care, Jefferson explored alliances and partnerships. 
In August 1995 Thomas Jefferson University and the Main Line Health System 
signed an agreement establishing a new, nonprofit, corporate entity known as 
the Jefferson Health System, an integrated health care delivery system, including 
Thomas Jefferson University Hospital, Methodist Hospital, Bryn Mawr Hospital, 
Bryn Mawr Rehab, Lankenau Hospital, and Paoli Memorial Hospital. In the 
years since then, other strong and well managed institutions joined JHS, 
including the Albert Einstein Healthcare Network, Frankford Health Care 
System, and Magee Rehabilitation Hospital. 
Albert Einstein Healthcare includes Albert Einstein Medical Center, 
Germantown Community Health Services (comprising an outpatient center and 
nursing home), MossRehab, Willowcrest (a center for subacute care), Belmont 
Behavioral Health, and a number of outpatient and satellite locations. 
Frankford has hospitals in the Frankford and Torresdale sections of 
Philadelphia and in Bucks County. 
Thomas Jefferson University, which is composed of Jefferson Medical College, 
the College of Graduate Studies, and the College of Health Professions, is the 
primary academic affiliate of the Jefferson Health System. An Education and 
Research Committee, chaired by the dean of the medical college, advises the JHS 
board on academic and research activities. The President of Thomas Jefferson 
University is the Chairman of the Board of the Jefferson Health System. 
JHS's mission is "To improve the quality of life by providing comprehensive, 
cost effective, state-of-the-art health services for defined populations; to be 
actively involved in education in clinical practice; and to encourage research 
related to the advancement of health care delivery." 
The university and the health system, while they are separate entities, are 
partners, recognizing the symbiotic nature of patient care, education, and 
research. They share an emphasis on what is best for the patient, and they rely 
on each other for their mutual success. 
Community based and decentralized, JHS is based on collegiality and consensus. 
Douglas Peters, the system's President and CEO, emphasizes that "Every 
decision is geared toward enabling each member institution to continue 
providing excellent health care in its respective community. It is quality and 
sensitivity, 'the human touch,' that set JHS apart." 
Each institution is responsible for its own daily operations, and plays a part in 
governing the whole system. The central office approves budgets for each of the 
member institutions, conducts strategic planning, and consolidates debt (which 
permits more favorable financing). 
In addition to its full members, JHS has forged strategic alliances with 
Christiana Care Health System in Wilmington, Delaware, Pottstown Memorial 
Hospital, Riddle Memorial Hospital, Underwood Memorial Hospital in 
Woodbury, New Jersey, and AtlantiCARE in Atlantic City, New Jersey. JHS has 
strong ties with duPont Hospital for Children in Wilmington. 
This breadth enables the Jefferson Health System to offer health care from 
infancy to late adulthood, across a major geographic area. Besides acute care, it 
is a market leader in behavioral health, rehabilitation, home health, senior 
services, and alternative (integrative) medicine. 
Operating costs can be streamlined when the institutions work together. There 
are 3,600 licensed beds and a medical staff of several thousand in JHS member 
institutions. Substantial money is being saved by consolidating judiciously, and 
rethinking areas such as energy use, and sources for laundry services. The 
system is working toward a joint billing system, as well as integrated clinical 
information software. 
Philadelphia is one of the most competitive health care markets in the country, 
in part because it has far more hospital beds than are needed by its population. 
Experts predict that cost-cutting pressures will grow even tighter. 
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At present, the Jefferson Health System and Thomas Jefferson University are 
both in solid financial positions, and their bond issues are given unusually high 
ratings. Jefferson's overall finances are the strongest of any health system in the 
Philadelphia area, according to Susan E. Hill, public finance director for 
Standard and Poor's, the bond rating agency. "One of their advantages is that 
they didn't go overboard with buying physician practices," she told the 
Philadelphia Inquirer. 
Jefferson Health System's $1.88 billion in fiscal 1999 revenues make it the 
largest health system in the nine-county metropolitan area. Its market share 
based on revenue is 21 percent. 
Conveniently located throughout the Philadelphia region are satellites of the 
Jefferson Health System. Some of the ambulatory care facilities are almost like 
hospitals without inpatient beds; others are smaller, more like extensions of 
physicians' offices. Spacious facilities have been opened in Upper Providence, 
Exton, Lawrence Park, and Voorhees, New Jersey. 
More than 600 primary care physicians are associated with JHS, in addition to 
numerous medical and surgical specialists. Jefferson HealthCARE is the network 
of conveniently located doctors including Great Valley Health physicians, 
JeffCARE physicians, and duPont Hospital for Children physicians. JeffCARE is 
a physician-hospital organization that brings together Jefferson Medical 
College's full-time faculty (Jefferson University Physicians, comprising approxi-
mately 460 clinicians), its volunteer faculty, and the hospital. JHS participates in 
some risk contracting (assuming risk by agreeing to care for a group of patients 
with a set amount of money). Stanton Smullens '61 (see page 11) is the system's 
Chief Medical Officer, and Chair of the JHS Quality Council. 
JHS maintains an informative Website at www.jeffersonhealth.org 
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 Philadelphia 
today, looking 
northward, 
with the 
Delaware River 
at right and 
the Jefferson 
campus at 
the center 
Dr. Brent with Robert A. Peterson, 
Vice President for Development; Ed 
Goldsmith, former president of the Bock 
Charities; Larry Ruttenberg, treasurer 
and former president of the charities; 
Mr. Bock; and Emanuel Rubin, M.D., 
Jefferson's Gonzalo E. Aponte Professor 
and Chair of Pathology, Anatomy, and 
Cell Biology, a department that is also 
involved in the new lectureship. 
Local Charities 
Strengthen Research 
• The Harry Bock Charities, Incorporated 
of Lafayette Hill, Pennsylvania recently 
donated $177,000, the balance of their 
assets, to initiate the Myra, Harry, and 
Fran Bock Prize and Lectureship in 
Pediatrics and Developmental Biology at 
Jefferson. 
University to Expand Neuroscience Programs in Wills 
Building as Wills Constructs a Sophisticated Eye Facility 
rpie university is purchasing the 
I Wills Eye Hospital building at 
Ninth and Walnut Streets, adjacent to 
the Jefferson campus. Jefferson will use 
the space to further develop the 
neurosurgery program (much of which 
is already located there). The eight-
story, 230,000-square-foot facility had 
served as Wills's home since 1980. 
Wills Eye Hospital will build a new 
facility on top of the Walnut Towers 
building at the southeast corner of 
Walnut and Ninth, directly across the 
street from its current building. Wills 
already maintains office space in 
Walnut Towers. The new state-of-the-
art facility, due to open in 2002, will be 
designed to deliver primary and 
specialty ophthalmology services in a 
more cost-effective ambulatory setting. 
Wills will maintain access to operating 
rooms and a small number of inpatient 
ophthalmology beds in its current 
facility. 
"The moving of Wills is our pre-
positioning strategy for the economic 
and market forces that lie ahead," 
explained D. McWilliams Kessler, 
Wills Executive Director and CEO. 
"In ophthalmology, we stopped 
needing inpatient beds for most of 
our business eight or nine years ago. 
We'll tailor our new tower to the 
outpatient demands of the specialty, 
and state-of-the-art residency 
training." The new structure will 
contain significantly more research 
space than at present. 
Wills will cease being an inpatient 
hospital, and will become a regional 
network providing day surgeries. Its 
outpatient surgical centers will 
number about 15, stretching from 
suburban Philadelphia to central and 
southern New Jersey. More than 95 
percent of eye surgeries now require 
no hospitalization. 
Jefferson will use the former Wills 
space to expand its neuroscience 
programs. During the past decade, the 
university has moved to the forefront 
in many areas of neurology, including 
stroke, Alzheimer's disease and 
dementia, and Parkinson's disease. 
Jefferson's neurosurgical programs 
treat epilepsy, spinal cord injuries, 
spinal disease, vascular brain disease, 
brain tumors, pain, headache, and 
other disorders, employing the latest 
technologies such as focused beam 
radiation by gamma knife, linear 
accelerator, and interventional 
neuroradiology. 
With the sale of the building, the 
Jefferson-Wills neurosurgery program 
will come under the sole operation of 
Jefferson. 
Wills and Jefferson have a 
longstanding academic and clinical 
relationship. Wills will continue to 
serve as a center for ophthalmic 
teaching and research. Its physicians 
serve as Jefferson's Department of 
Ophthalmology and Jefferson medical 
students rotate through Wills as part 
of their training (see cover photo). 
The residency and fellowship 
programs are extensive. 
"Friends, family, and business associates 
of my father founded the Harry Bock 
Charities in 1958 to help crippled 
children. In the years since he passed 
away, our giving has evolved to aid 
Jefferson's efforts to prevent birth 
defects," said Hoagy Bock, who has 
served as president of the Charities. 
"Giving the remainder of the Charities' 
assets to endow a fund at Jefferson in 
honor of my mother and in memory of 
my father and my sister Fran is a 
wonderful way to continue this legacy." 
During the past 34 years, the Bock 
Charities and Bock family contributed an 
estimated $700,000 to the Harry Bock 
Laboratories, which originally were 
located on the Jefferson campus and now 
are at the duPont Hospital for Children 
(affiliated with the Jefferson Health 
System). Under the leadership of Robert 
L. Brent, M.D., Ph.D., the Louis and Bess 
Stein Distinguished Professor of 
Pediatrics at Jefferson, the Bock 
Laboratories' clinical and environmental 
teratology investigations have focused on 
the environmental and genetic causes of 
birth defects. The newly created Bock 
Prize and Lectureship, which brings the 
Bock Charities' generosity to Jefferson to 
nearly $1 million, will further research in 
these areas. 
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Alumni Trustees Report 
MacMaster is Trustees Chair-elect to Succeed Farber 
"The new prize and lectureship will help us attract 
distinguished specialists and researchers who will 
share their expertise with the Jefferson community," 
said Dr. Brent. "Such exchanges of information and 
ideas are vital to our mission, and they benefit our 
patients." 
• The W. W. Smith Charitable Trust of Newtown 
Square, Pennsylvania recently awarded grants to 
Ulrich Rodeck, M.D., Associate Professor of 
Dermatology and Cutaneous Biology, and Yuri K. 
Sykulev, M.D., Ph.D., Assistant Professor of 
Microbiology and Immunology. 
Dr. Rodeck will receive $157,000 from the trust to 
study how transforming growth factor b (TGFb) may 
have a role in suppressing or supporting the 
malignant expression of human melanoma. This will 
help determine whether tumor therapy can target 
TGFb in the future. 
Dr. Sykulev will receive $59,000 from the trust to 
support his research on the role of cytotoxic T 
lymphocytes (CTL) in providing immunity to HIV. 
This could aid the development of a safe and effective 
vaccine against HIV. 
The W. W. Smith Charitable Trust and the Mary L. 
Smith Charitable Lead Trust have awarded Jefferson 
more than $3 million for basic and clinical research 
in heart disease, AIDS, and cancer. In addition, the 
W. W. Smith trust made a special onetime grant of 
$1.5 million to endow the William Wikoff Smith 
Chair in Cardiac Research, currently held by Andrew 
Zalewski CD'84. 
• The Philadelphia-based Margaret Q. Landenberger 
Research Foundation awarded Hui Zhang, M.D., 
Ph.D., a molecular biologist who is an Assistant 
Professor of Medicine, a one-year grant of $35,000. 
Dr. Zhang has advanced our knowledge of 
retroviruses such as HIV-1. His research was instru-
mental in the discovery of a new phase of the 
retroviral life cycle—intravirion reverse 
transcription—and his data has been used to design 
treatment regimens that inhibit maternal-to-fetal 
transmission of HIV-1. The grant from the 
Landenberger Foundation will enable Dr. Zhang to 
work on effective treatments for HIV-1. 
Mrs. Landenberger, whose family has been treated at 
Thomas Jefferson University Hospital, established 
her foundation in 1993. It has provided the 
university with more than $215,000 to support 
investigations into HIV-1, cancer, diabetes, and 
vascular disease. 4 
• Jack Farber will retire from the chairmanship of 
the university's Board of Trustees effective July 1, 
and the trustees have elected Douglas J. MacMaster 
Jr., an attorney and retired Senior Vice President of 
Merck, Incorporated, the pharmaceuticals firm, as 
the new Board Chair effective July 1. Mr. MacMaster 
has proven himself an enthusiastic and active 
trustee, a worthy successor to Mr. Farber. 
• The tight health care environment in the Delaware 
Valley is squeezing academic medical centers, and 
the fiscal burden on Jefferson can be expected to 
worsen as the effects of the Balanced Budget Act of 
1997 decrease reimbursements to teaching hospitals 
at the same time that managed care cost pressures 
are expected to increase. Thomas Jefferson 
University Hospital is presently in the black, but 
constant vigilance and prompt responses to change 
are imperative to stay ahead. 
• Roy Proujansky, M.D., a pediatric gastroenterol-
ogist at the duPont Hospital for Children (a close 
affiliate where most of Jefferson's pediatric activities 
are located), has been appointed Chair of Pediatrics 
at Jefferson Medical College. 
• The market share of the Jefferson Health System is 
21 percent, the largest inpatient market share in the 
Delaware Valley. The system has the largest share in 
every field except pediatrics. The present financial 
position of the Jefferson Health System is distinctly 
more stable than other health systems in the region. 
• Gifts to Jefferson in 1998-99 totaled $23.4 million. 
Total alumni giving, including annual giving, 
bequests, and newly created trusts, was $6.6 million. 
Stratton Portrait 
The latest addition to the university's collection of 
portraits is James W. Stratton as painted by Dean 
Paules. The portrait was 
presented to the university 
in September to honor the 
former Chairman of the 
Board of Trustees, who 
led Jefferson during a 
period of unprecedented 
growth from 1990 to 
1994, setting a fine 
precedent for chairman 
Jack Farber. 
• Jefferson's increased research activity over the 
past decade, as measured by grants from the 
National Institutes of Health, presently places 
Jefferson in the 39th position, or upper third 
nationally, of the 125 medical schools in the U.S. 
Among the fruits of this improved research 
position are an enhanced reputation for Jefferson, 
and the development of new drugs and patient 
care techniques. Currently 18 drugs developed at 
Jefferson are undergoing clinical trials, and many 
more are in preclinical development. Jefferson's 
Office of Technology Transfer watches over the 
university's rights to inventions resulting from 
federally funded research; secures patents on new 
discoveries and technologies; licenses these 
patents to existing companies in return for 
research funding for the university; and helps in 
the development of new companies to produce 
and market Jefferson discoveries (in return for 
which the university receives stock in these new 
companies). Revenue to the university from 
licensing fees, research funding from corpora-
tions, and new stock received in 1998-99 totaled 
$5.6 million for the year. This amount is expected 
to increase in future. 
• The institutions's dramatic increase in 
researchers and research activities over the past 
decade has tightened the squeeze on campus real 
estate. We are now out of laboratory space, a 
situation that, unfortunately, coincides with our 
being on the brink of enormous changes in 
medicine brought about by advances in molecular 
biology. Recognizing that our present "lab locked" 
position is detrimental to Jefferson's long-term 
growth, the Board of Trustees has authorized the 
construction of a new cancer building atop the 
present Jefferson parking garage along Locust 
Street between 10th and 11th. This new structure, 
which will house both cancer researchers and 
clinicians, will consist of five completed floors and 
two shell floors at a projected cost of $173 
million. Of this, $31 million has already been 
committed by two anonymous donors. The 
university has secured a construction loan, a 
starting date of spring 2000, and a two-year 
completion estimate. 
Robert Poole 111 '53 
John J. Gartland S'44 
Allen E. Chandler '61 
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Nobel Prizewinner Ferid Murad 
Describes Cellular Signaling 
More than 40 different speakers made presentations about 38 different 
subspecialties at Career Day, presented by the alumni association. Chaired 
by Lori DePersia '81 and Rudy DePersia '81, it offers sophomore students a 
chance to hear about various fields of medicine from practicing physicians. 
e recipient of the 1998 Nobel Prize in 
Physiology or Medicine, Ferid Murad, 
M.D., Ph.D., delivered the Rehfuss 
Lecture at Jefferson in October. Currently 
the Chair of Integrative Biology and 
Pharmacology at the University of Texas, 
Houston, Murad described his pioneering 
work on the role of nitric oxide and cyclic 
GMP in cellular signaling. 
Physicians have long used nitroglycerin to 
treat angina and coronary artery disease. 
Murad discovered that this and related 
drugs treat coronary artery disease by 
releasing nitric oxide gas. Previously 
known only as an environmental 
pollutant, nitric oxide is a natural product 
of various tissues in the body, including 
the endothelial cells lining blood vessels. 
Indeed, nitric oxide produced by 
endothelial cells or by nitroglycerin 
induces smooth muscle cells 
surrounding blood vessels to relax, 
allowing more blood to flow to oxygen-
starved myocardium to relieve the 
symptoms of angina in coronary artery 
disease. 
Murad's lecture at Jefferson focused on 
how nitric oxide is used by cells to signal 
to each other, sometimes from distant 
parts of the body, in order to work in 
concert. The human body can be 
conceived of as a federation of cells 
which must work together to survive. 
A role for nitric oxide is being examined 
in a number of medical conditions 
including stroke, pulmonary hyper-
tension, and erectile dysfunction. It may 
eventually be used in the treatment of 
many other disorders. (it 
Jamie Wells '01 
Adapted from the April 1999 JMC 
Student Examiner 
ould it be the bleakness of winter? I 
k..—/think not. The spring-like days that 
have been interspersed with 
the cold ones compel me to 
think that Seasonal Affective 
Disorder is not the most 
reasonable conclusion 
(our neuroscience professor, 
George Brainard, is a national 
expert on sAD). Well, if it's not 
the weather, then what can 
explain the pervasive negative 
attitudes that I have encountered this 
week? 
When I run into classmates I haven't seen 
for awhile, I seize the opportunity to 
catch up with them. But the following is 
much too typical of students at all the 
medical schools in the city: 
Classmate: "Hi Jamie, how are you?" 
Me: "Fine, thanks—and you?" 
Classmate: "As best as could be expected." 
"As best as could be expected"?! What, 
does this individual have a terminal 
illness? One person said, "I'm, you know, 
just plugging away waiting for the life we 
are going to have when we graduate." 
Whoa! Don't include me in that "we." 
Admittedly our lifestyle now is not the 
most ideal, but when you expend the 
necessary energy to rectify it you can be 
amazed at the very attainable 
improvement. 
I myself voiced that sort of negative 
response my first year of medical school. 
It was, for me, the first true challenge of 
how to achieve balance in my life. But the 
learning curve since then has been 
extraordinarily high. When you practice 
balancing, you can achieve it. 
I never felt satisfied with a negative 
mentality. I will never forget talking to a 
guy in my class while on the fourth floor 
of the library during the fall of first year. 
He said to me, "I am not even going to 
consider dating for the next four years." 
Can anyone explain to me how life, and 
the precious nature of it, completely 
eluded this poor soul? 
I just hope that if I made such statements 
someone would give me a fast and furious 
wakeup call. Life is short. It is valuable 
and it is fleeting. I rue the day that I ever 
become complacent about it. 
That guy is not entirely 
culpable. The medical track is 
responsible for instilling 
within so many of us the 
notion that the next thing is so 
much better. Let me do well in 
college to get to medical 
school. Let me do well in 
medical school to get a better 
residency, which if I do well 
in I can get the better fellowship, and on 
and on . . 
But I'm willing to do whatever it takes to 
break the cycle of wishing away my life. 
The reality is that if this guy spends all 
four years of medical school neglecting 
his friends and family and for some 
unknown reason, say health or 
academics, finds himself no longer 
having medical school, then what does 
he really have? 
Or what if he makes it through the 
required hierarchy, but finds himself 
miserable at the finish? Would he ever be 
able to justify the loss of 10-plus years of 
his life? 
I am not purporting to have solved the 
dilemma of being a successful medical 
student who is also a liver of life. But I 
can claim, with each passing day at Jeff, to 
have gotten better and better at 
reconciling the two. How? By staying true 
to what made me pursue a career in 
medicine in the first place: I have set out 
to take advantage of life. 
Angst is typical of our age—and a medical 
student lifestyle makes everything more 
intense. But it's astounding what a 
deliberate change in your perspective can 
do. And the more upbeat a person is in 
his private life, the more productive he 
will be in his professional life. 
If a classmate asks me how life is going, 
I'll respond pretty enthusiastically. Watch 
out—happiness can be infectious. it 
HEARD ON CAMPUS 
Wakeup Call! We Can Be Students 
AND Have a Life! 
Jeff Hosts International 
Convention of 
Medical Students 
r 
 ,hey came from Peru, Brazil, Denmark, Turkey, 
Zimbabwe, Ghana: more than 450 medical 
students and physicians from around the globe came 
to Jefferson in January for the Sixth Annual National 
Convention of the USA-International Health Program. 
Speakers described their experiences in health care 
around the world. 
Highlights included: Vincent Orinda, M.D., 
Senior Advisor of Child Health, UNICEF; 
Sharon Savage, M.D., of the Rainforest Health Project 
describing "Medicine in the Amazon Basin: 
Incorporating Local Healers with Western Medicine": 
Jerry Ehrlich, M.D., of Doctors without Borders, 
on "A Mission without Borders: An American 
Pediatrician in Sri Lanka." Doctors Without Borders, 
based in France, 
has won the Nobel 
Peace Prize for its 
work in lands 
ravaged by war. 
Other speakers 
described their 
experience with 
global disease control programs, 
global child health problems, 
alternative medicine in China, 
and medical student exchange 
programs in Eastern Europe 
and Africa. 
The goal of the USA-International 
Health Program is to provide U.S. 
medical students with interna-
tional medical exchange opportunities. The USA-IHP is a member of the 
International Federation of Medical Student Associations, which held its 
executive meetings at Jefferson in January in conjunction with the convention. 
The federation promotes exchange programs at medical schools in 69 countries. 
"It's owing to our students' initiative that Jefferson has become a lead institution 
in this organization," said Jussi Saukkonen, M.D., Dean of Graduate Studies 
and University Vice President. 
Jeff student Olita Layton '01 is the Editor of Vagus, the quarterly newsletter of 
the international federation. She explained that her newsletter—like the 
federation—seeks to be like a vagus, a nerve that reaches through medicine 
around the world to connect distant centers. 
Jefferson maintains cooperative programs with the International Medical College 
in Malaysia, the Noguchi Institute in Japan, and institutions in Uganda and 
elsewhere. The university's Foerderer Fund provides scholarships for students 
to study abroad.' 
Icarus Lands in 
Jeff Hall Atrium 
A sculpture of Icarus, the youth of 
Greek myth who thought he could fly 
as high as the gods, has been installed 
in the atrium of Jefferson Alumni 
Hall. It is a gift from Gail and 
Edward L. Snitzer (Mrs. Snitzer's 
father was Edward Weiss '17). It 
shows Icarus as he plummets, the sun 
having melted the wax in the wings 
made by his father Daedalus (who 
with the wisdom of maturity, steered a 
middle course and survived the flight). 
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New Test Is More Accurate at Measuring Cancer Spread 
hysicians at Jefferson have 
devised a blood test they believe 
will tell patients whether their 
colorectal cancer has returned. The 
test looks for the presence of a 
protein, GCC, to detect the spread of 
colorectal cancer to the lymph nodes. 
It may help doctors to provide more 
appropriate treatment. 
Scott Waldman, M.D., Ph.D.'80, the 
Samuel M. V. Hamilton Family 
Professor and Director of Clinical 
Pharmacology, and his colleagues 
examined 21 colorectal cancer 
patients. One group of 11 had been 
disease-free for at least six years and 
were deemed "cured." The other 
group of 10 patients had developed 
recurrent cancer within three years 
after surgery. The latter group had 
also been told initially that they had 
no signs of cancer in their lymph 
nodes after surgery. 
The scientists examined lymph node 
samples of each patient for the 
presence of GCC. They found that the 
disease-free patients' lymph nodes 
showed no signs of the protein 
marker. Conversely, GCC was 
present in every patient whose cancer 
had returned. They reported their 
results December 7 in the Annals of 
Internal Medicine. 
"The findings suggest that the test can 
be used to detect metastatic colorectal 
cancer during the staging of these 
patients," Dr. Waldman says. "It is 
more sensitive than current 
histological methods and the results 
correlate with disease progression." 
Colorectal cancer is the third most 
common cancer in the nation, with 
some 200,000 new cases diagnosed 
annually. It is best treated when 
found early. "The single best 
predictor of how a patient will do is 
whether the disease is still confined to 
the intestine," Waldman says. "If 
microscopic seeds have escaped to the 
lymph nodes, then when a surgeon 
takes out the cancer, he invariably 
leaves some behind." 
As many as 40 percent of colorectal 
cancers originally thought to have 
been cured by surgery alone return in 
three years. 
Surgeons remove lymph nodes during 
surgery and pathologists examine 
them under a microscope for cancer 
cells. But often cancer cells are 
missed, and physicians would like a 
more sensitive and accurate method 
to find disease in the lymph nodes. 
"This was a retrospective study, 
conducted after the patients had 
been diagnosed," Waldman points 
out. "We knew their diagnoses 
ahead of time and we specifically 
selected them. Now we want to 
do a large prospective study." If 
Waldman's initial results hold up in 
larger clinical trials, doctors may be 
able to use the test immediately after 
surgery for diagnosing metastatic 
disease outside the intestine, which is 
important in deciding about 
chemotherapy. 
"We hope this marker is sensitive and 
specific for metastatic colorectal 
cancer," he says. "We want to be able 
to take lymph nodes judged clean by 
pathologists in patients told they have 
disease confined to the intestines, and 
find disease we wouldn't have found 
until much later." 
Waldman sees the marker as a useful 
diagnostic tool for the long run as 
well. "It could be used as a blood test 
to follow patients after surgery to 
determine if they have recurrent 
disease," he explains. "If any is 
detected, the doctor could intervene 
immediately." 
He plans to enroll between 1,000 and 
2,000 patients in a prospective, five-
year study comparing the ability of 
the standard histological examination 
of lymph nodes to that of the GCC 
marker test to predict recurrent 
disease. 
GCC, or guanylyl cyclase C, is a 
family of seven proteins expressed 
only by intestinal cells and colorectal 
cancer cells. It's vital to cellular 
communications, transmitting signals 
from outside to inside the cell. It 
turns out that most sporadic 
colorectal cancers originate in the 
cells that line the intestine—cells that 
normally make GCC. When the cells 
become cancerous, they continue to 
make GCC. 
A Protein May Predict Long-term Breast Cancer Survival 
novel protein may 
predict the long-term 
survival of women with 
early-stage breast cancer. 
Jefferson researchers have 
shown that high levels of 
BAG-1 correlate with a 
better chance of living 
disease-free longer, and living longer 
overall. BAG-1 is a protein that 
inhibits apoptosis, or programmed 
cell suicide. 
Bruce C. Turner, M.D., 
Ph.D., Assistant Professor 
of Radiation Oncology, 
along with John C. Reed, 
M.D., Ph.D. of the Burnham 
Institute in La Jolla, 
California, and colleagues 
at Yale University looked at 
116 women with early-stage breast 
cancer, following them for an average 
of more than 12 years. They found that 
on average, a woman in this group 
whose breast tumor carried high 
amounts of BAG-1 protein had an 
overall 10-year survival of 81 percent. 
A similar woman whose tumor did not 
have BAG-1 had, on average, only a 50 
percent chance of living 10 years. 
"The difference in survival between 
these categories of patients is quite 
large. So we think we have come up 
with a novel marker that may be an 
important diagnostic test for 
physicians to predict metastatic 
disease," says Dr. Turner. The 
researchers have also developed 
immunohistochemical and antibody 
techniques to isolate the protein. The 
finding "may influence subsequent 
therapy by suggesting that these 
women need more intensive treatments 
such as high dose chemotherapy, 
hormonal therapy, or concurrent 
radiation and chemotherapy," he says. 
continued on page 20 
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Rb2 Gene Therapy Shrinks Tumors in Mice 
esearchers at Jefferson are the 
first to dramatically shrink lung 
cancer tumors in mice by replacing a 
damaged Rb2 gene with a healthy 
version. Showing that the normal gene 
can actually reverse tumor growth 
constitutes direct evidence that Rb2 is 
a tumor suppressor. It could eventually 
be used in human gene therapy trials 
for lung cancer. 
Rb2 is an important master switch in 
controlling the equilibrium of the cell. 
"We're the first to show that this tumor 
suppressor gene has been heavily mu-
tated in primary tumors," says Antonio 
Giordano, M.D., Ph.D., Associate 
Professor of Pathology, Anatomy, and 
Cell Biology. "The mutation prevents it 
from functioning and suppressing the 
tumor. We've shown that Rb2 is a 
classic tumor suppressor gene, similar 
to the well known p53." 
Tumor suppressors such as p53, 
which may be involved in half of all 
human cancers, are normal growth 
control genes. They contribute to 
cancer when they malfunction. Rb2 
is normally expressed in all tissues of 
the body. 
Giordano and colleagues at Jefferson, 
the University of Naples, the 
University of Siena, Bristol-Myers 
Squibb, the University of Texas 
Southwestern Medical Center, and the 
Sbarro Institute (which is affiliated 
with Jefferson) have developed a gene 
therapy model using a retrovirus as the 
delivery system. They inserted the 
Rb2/p130 gene inside the virus vehicle 
and introduced it into cell lines of 
human non-small cell lung cancer that 
were grown in the laboratory. The 
cancer cell lines were injected into 
mice, which as a result grew tumors. 
But the Rb2 suppressed the tumor 
growth. 
Such therapy may someday be possible 
in humans. Non-small cell lung cancer 
is the most dangerous and prevalent 
type, making up about 75 percent of 
lung cancer cases in humans. 
The next challenge for Jefferson 
researchers is to understand precisely 
how a dysfunctional Rb2 gene leads to 
the cancer. "We have discovered three 
different mechanisms by which it can 
cause tumors—which shows that Rb2 
is a major guardian of the genome, a 
major controller of cellular processes," 
Giordano says. 
In one of several recent papers in the 
journal Cancer Research, Giordano's 
team described one of those 
mechanisms. They already knew that 
some lung cancer cells lack a working 
Rb2 gene, because they had 
demonstrated a reduction in the 
protein it makes. But in some types of 
cancer in which Rb2 is heavily 
mutated, such as nasopharyngeal 
cancer (which is common in southern 
China), they found that the mutation 
caused a cell signaling problem that 
contributed to the cancer. 
In another article, Giordano's group 
showed that the Rb2 protein can be 
misplaced within the cell in Burkitt's 
lymphoma. 
There are other evidences of Rb2's 
role in causing cancer. In earlier work, 
Giordano showed that Rb2/p130 
proteins throughout the body's tissues 
play vital roles in controlling cell 
growth. If they are missing, cancer 
may result. 
And in 1998, Dr. Giordano reported 
that five years after endometrial 
cancer surgery, lower levels of the Rb2 
proteins correlated with a higher-
than-normal risk of returning disease. 
"Rb2 is part of a small group of tumor 
suppressors, but it behaves differently 
than other tumor suppressors. In 
some cancers, Rb2 may not be 
mutated," he says. "As far as putting 
our hypothesis to use, one of the 
biggest challenges is to refine the virus 
delivery system for gene therapy." 
Rb2 Gene May Improve Angioplasty Results 
Jefferson investigators have found that Rb2/p130, 
a protective anticancer gene (see above), may have 
another usefulness as an adjunct to angioplasty in 
treating blocked coronary arteries. Rb2/p130 puts 
the brakes on runaway cells, halting rapid growth. 
Its main function is to prevent potential tumors 
from growing, holding back a cancerous tendency 
of a cell. 
The scientists, led by Pier Paolo Claudio, M.D., 
Ph.D., Assistant Professor of Pathology, Anatomy, 
and Cell Biology at Jefferson, and Giancarlo 
Condorelli, M.D., Ph.D. of the University La 
Sapienza in Rome, showed in rats that Rb2/p130 
may have therapeutic potential for treating 
clogged arteries. 
In some chronic diseases, arteries are blocked due 
to excessive smooth muscle cell buildup on artery 
walls. Physicians frequently turn to angioplasty, in 
which a balloon attached to a catheter is expanded 
to break up the blockage. But a third or more of 
patients, within three months, experience reclogged 
arteries. This may be because angioplasty triggers 
biochemical signals that cause normal cells in the 
artery wall to grow again. 
Dr. Claudio and his coworkers used adenoviruses to 
deliver the Rb2/p130 gene into the arteries of rats 
with simulated coronary disease. After 20 days the 
researchers measured the levels of Rb2/p130. The 
gene continued to show a "pronounced expression 
in the arterial walls, preventing the proliferation of 
smooth muscle cells and restenosis," he says. The 
scientists reported their findings November 26 in 
Circulation Research. 
"Physicians want to give the wall time to repair the 
slight damage caused by angioplasty, but we don't 
want to allow the smooth muscle cells to proliferate 
and clog the artery," Claudio explains. 
Now he is testing the treatment in transgenic mice 
that carry the human genes for high cholesterol and 
have chronic heart disease and clogged arteries. The 
chronic disease in mice is closer to the human 
disease condition. If the treatment works, scientists 
may use it in human trials in the future. 
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BAG-1 Protein continued from 18 
Kyonggeun Yoon, 
Ph.D., Associate 
Professor of 
Dermatology and 
Cutaneous Biology, 
and postdoctoral 
fellow Vitali 
Alexeev, Ph.D., in 
collaboration with a 
team of scientists at 
the University of 
Pennsylvania, 
corrected a single 
alteration in the 
gene that controls 
skin color in albino 
mice cells. The 
scientists, in what 
they dub "localized 
gene therapy," delivered a small 
oligonucleotide (DNA interspersed 
with small amounts of RNA) to the 
melanocytes, cells that produce skin 
color. The "oligo" triggers the actual 
gene repair process. They injected the 
oligonucleotide and also applied it 
topically. 
As described in the January issue of 
Nature Biotechnology, "we showed 
that it's possible to change the hair 
color in a live animal, not just in the 
color-producing cells cultured in a 
test tube," says Dr. Alexeev. At this 
early stage, only a few tiny hairs were 
oligonucleotide to the melanocytes," 
says Yoon. "We're still trying to find 
the optimum conditions for delivery 
of the oligonucleotides into mouse 
skin. The skin is a good organ for 
these types of experiments, because 
it's accessible and easy to monitor for 
changes." One reason the researchers 
are refining the delivery system is that 
mouse and human skin differ. 
In the albino mice, the gene 
alteration, of the type known as a 
point mutation, was in the gene for 
tyrosinase, an enzyme that is involved 
in making melanin and in pigmen-
tation. When the scientists corrected 
the alteration with gene repair, 
that has the capability to find and 
attach itself to a certain part of a gene. 
The small genetic vehicle is designed 
to trigger the cell's normal DNA 
repair system into action as well. The 
repair mechanism scans the DNA 
looking for mismatches: two strands 
of DNA that aren't in sync. When it 
finds a mismatch, it replaces one of 
the chemical bases with a base that 
fits properly. The scientists can use 
this natural repair system to correct a 
bad mutation. 
"We need to do more studies and 
improve the design," Yoon notes, "to 
make this technology generally 
applicable." 4 
The scientists tested tumor tissue from 
each woman in the group, measuring 
levels of BAG-1. They found that 
compared to other potential cancer 
markers, such as p53, estrogen 
receptors, Her2/Neu, the disease 
"stage," and Bcl-2 (another anti-
apoptosis gene that predicts for 
survival), BAG-1 was best able to 
predict survival after 10 years. 
"This could be useful to us in deciding 
how to treat early-stage breast cancer 
patients, especially those who have 
negative lymph nodes, because for 
those patients the use of high dose 
chemotherapy and other therapies 
remains controversial," Turner says. 
"If we can identify women with 
negative lymph nodes who are at risk 
of developing metastatic disease using 
this marker, it might be reasonable to 
treat them with chemotherapy. That 
may not be the case for patients with 
high levels of BAG-1 and therefore 
good chances of survival. 
"The important finding from this 
study is that BAG-1 is an important 
predictor of survival in patients who 
have pathologically negative lymph 
nodes and are at a low risk for 
developing metastatic disease," he 
says. "It's frequently difficult to make 
decisions regarding therapy for these 
women. Now we know that women 
with negative lymph nodes and low 
levels of BAG-1 are at risk of 
developing metastatic disease and may 
be good candidates for aggressive 
treatments. 
"BAG-1 is not only a marker for 
survival in breast cancer patients, but 
more importantly, it's a marker for 
survival of women with negative 
lymph nodes. It's independent of 
lymph node status." 
The next step, Turner and Reed say, is 
to perform larger, prospective studies, 
looking at thousands of women to 
ascertain that this marker is a top 
predictor of survival. 4 
Gene Repair Changes Albino Hairs to Black, 
Eventually Will Treat Inherited Disease 
nvestigators at Jefferson have used 	 blackened, and they were not visible 	 tyrosinase activity was restored and 
an innovative "gene repair" 	 without a microscope. 	 melanin was again produced. 
technique to genetically change white 
albino mice hairs to black. The 	 Last year, Yoon and Alexeev reported 
	
Yoon used the technique on melanin- 
technique has not only turned hairs 	 that, using this gene repair technique, 	 producing cells as a model system to 
black, but has showed that such 	 they could change mouse melanocytes 	 test a hypothesis. "We wanted to see 
changes are stable and longlasting in 	 from white to black in the test tube. 	 what we could visualize and follow 
skin cells. The work holds promise as 	 using this system." She and colleagues 
a treatment for some hereditary 	 The scientists are continuing to refine 	 developed the gene-fixing technique 
diseases by correcting the genetic 	 their technique. "We have a lot to 	 several years ago. Scientists can 
mutation from which they arise. 	 improve on, such as getting the 	 synthesize a small oligonucleotide 
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Shirley Foerderer Murray (left) and Florence Foerderer 
IN ME OR AM 
J. Wesley Tomlinson '27 died October 1, 
1999. Board certified in ophthalmology, he 
practiced in Sharon Hill, PA. He is survived 
by two sons. We have no further information 
at press time. 
Joseph Waldman '30 died October 21, 1999. 
A member of the Alpha Omega Alpha Honor 
Medical Society, he remained a lifelong 
learner with eclectic tastes. Board certified in 
ophthalmology, he practiced in Philadelphia 
and was an Honorary Clinical Professor of 
Ophthalmology at Jefferson. In addition to 
medical practice, he was an inventor and a 
patent holder. He is survived by his wife, 
Lillian, two daughters and a son. 
Raymond C. Davis '31 died August 30, 
1999. He was in family practice in 
Susquehanna, PA. He is survived by twin 
daughters and a son. We have no further 
information at press time. 
A. George Ricchiuti '32 died January 13, 
1999. Board certified in otolaryngology, he 
practiced in Mahanoy City, PA. He is 
survived by his wife, Margaret, and a 
daughter. 
Bernard A. Sage '35 died May 24, 1999. A 
Fellow of the American Academy of Family 
Physicians for 50 years and the American 
Occupational Medical Association's Society 
of Industrial Medical Physicians, he 
maintained a 30-year family practice in 
Dearborn, MI, and was a founding staff 
physician at Oakwood Hospital in Dearborn. 
He joined Ford Motor Company in 1966 
where he practiced industrial medicine until 
1977. A daughter and son survive him. 
Alan M. Schaeffer '40 died June 3, 1999. A 
member of the Alpha Omega Alpha Honor 
Medical Society, he was a fellow of the 
American College of Obstetricians and 
Gynecologists. He was on staff at Cooper 
Hospital, Camden, NJ, Rancocas Valley 
Hospital, Willingboro, NJ, and Zurbrugg 
Memorial Hospital, Riverside, NJ, where he 
was Chief of Obstetrics-gynecology. He is 
survived by his wife, Nancy, a son and a 
daughter. 
Nicholas J. Christ '42 died August 7, 1999. 
He was a family physician in Birdsboro, PA 
for over 50 years. He also served as President 
of the Birdsboro Board of Health for over 40 
years. He is survived by his wife, Margaret, 
and two sons. Son Peter is Jefferson '79. 
Joseph A. Kardos '51 died June 30, 1999. 
Board certified in anesthesiology, he was on 
staff at Stamford Hospital, Stamford, CT, and 
was Chief of Anesthesiology at St. Joseph's 
Medical Center. He is survived by his wife, 
Frances, four sons and three daughters. 
Romeo A. Luongo '54 died October 15, 1999. 
Board certified in otolaryngology, he 
practiced in Philadelphia. He was on staff at 
Methodist Hospital and was Chief of 
Otolaryngology at St. Agnes Hospital. He 
held a faculty rank at Jefferson as Adjunct 
Instructor in Otolaryngology-Head and 
Neck Surgery. He is survived by two 
daughters and a son. 
Domenic F. Coletta '55 died October 10, 
1999. Board certified in pathology, he 
initially served as Chief of Pathology at 
Roxborough Memorial Hospital, 
Philadelphia. Later, he became Chief of 
Pathology at Salem Memorial Hospital, 
Salem, NJ where he also served a term as 
President of the Medical Staff. He is 
survived by his wife, Mary Lou, three 
daughters and three sons. Son Anthony is 
Jefferson '79. 
Paul A. Andrulonis '72 died September 27, 
1999. Board certified in both adult and 
child psychiatry, he practiced in Hartford, 
CT. He had been Director of Training and 
Research in Child and Adolescent 
Psychiatry, Institute of Living, Hartford, 
and Associate Professor of Psychiatry, 
University of Connecticut School of 
Medicine. He later became Medical 
Director of the Community Programs 
Division for the Philadelphia Child 
Guidance Center, Philadelphia, and 
Assistant Professor of Psychiatry, 
University of Pennsylvania School of 
Medicine. A board examiner in adult and 
child psychiatry, he was published widely 
in his field of interest and had lectured 
extensively in this country and abroad. He 
is survived by his wife, Sylvia Marie, two 
sons and a daughter. 
Joseph Rupp '42 Remembered 
by Rachmel Cherner '55 
Joseph]. Rupp died peacefully on October 
2. He was a widely recognized endocrinol-
ogist, a prolific writer. a revered teacher. 
Rupp with a student in 1971 
His career at Jefferson ended with a long-
sought professorship on his retirement in 
1981. He is survived by his wife, Romaine, 
and five children. 
My first encounter with Dr. Rupp was in 
my junior year at Jefferson. He was 
conducting a workshop on thyroid diseases 
in the eighth floor classroom in the College 
Building. I remember an obese man who 
draped himself over a table in a half-
reclining position reminiscent of the 
ancient philosophers of Greece and Rome, 
discussing the subtle features of thyroid 
disease. Joe never won prizes for his dress. 
His standard uniform was usually old, 
baggy pants, always too large for him, 
sometimes stained, and the shirts he wore 
usually had the collar opened at the neck 
with a tie that sagged down and out. His 
checkered sports coat had seen better days. 
Numerous cigarettes were smoked with 
occasional cigars, without very much care 
as to where the ashes went. Although 
sartorial splendor was absent, his mind was 
racing yet neat and orderly, his speech 
always clear and succinct. He inspired 
many a budding endocrinologist. 
In the classroom or in the old surgical 
amphitheater, the "pit," his presentations 
were informative and amusing by turns. He 
expected his students, residents, and 
fellows to be well informed, and he did not 
suffer fools gladly. But he always found a 
way to be kind. 
Joe's prodigious memory not only covered 
internal medicine and endocrinology, but 
also English and French literature, music 
new and old, American history, and 100 
other subjects. Diabetic clinics at 
Jefferson's Curtis Clinic involved not just 
seeing patients and discussing the 
subtleties of their care, but also Elizabethan 
literature, Civil War battles, and 200 years 
of opera. 
Fancy Jefferson's collection of talent in 
endocrinology: Karl Paschkis, pioneer in 
cancer chemotherapy and endocrine 
physiology, Joe Rupp in thyroidology, 
Abraham Rakoff, pioneer gynecologic 
endocrinologist, and a dozen others. Unfor-
gettable were our get-togethers at the home 
of the Rupps, where Romaine Rupp 
provided magnificent Italian cooking. 
Joe was active as a basic researcher in 
thyroidology. He was deeply 
immersed in the pathogenesis of 
goiter and in the molecular 
physiology of the thyroid, with 
particular interest in the metabolism 
of thyroxine and thyronine/tyrosine 
and iodinated tyrosine residues. He 
was instrumental in establishing a 
specific genetic basis of goitrogenesis. 
He also directed a successful NIH 
program in cancer chemotherapy. He 
coauthored a standard textbook of 
endocrinology with Paschkis, Rakoff, and 
Abraham Cantarow, Professor of 
Biochemistry. In a clear and compelling 
style, this text "cut to the chase" in offering 
endocrine material to the student, house 
staff member, and general family physician. 
It went through several editions. 
Students at Jefferson would line up at six in 
the morning to sign up for Joe's lectures. He 
was extraordinarily popular with students, 
and was frequently proposed for teaching 
awards. He received the Lindback Teaching 
Award in 1964. 
Joe's accomplishments are even more 
amazing, considering that financial support 
for full time teachers was extremely limited. 
In those days before federal financing, 
research and teaching had to be done 
cheaply. Joe helped support himself and his 
family by conducting a small practice in the 
Byberry area of Northeast Philadelphia. 
Joe never talked about his service in Italy in 
World War II. There never was any 
braggadocio about the way his collection of 
medals, American and also foreign, had 
been earned. But we know that his bravery 
during combat as a battalion surgeon in the 
infantry had earned him a medal of the 
Legion of Merit as well as a Bronze Star. 
Faculty 
Moe H. Fred Friedman, Chairman, 
Department of Physiology, 1955-74, died 
October 25, 1998. Under Dr. Friedman's 
guidance, the physiology curriculum 
responded to the increasing importance of 
cellular physiology and biophysics. The 
department widened its research base, 
enlarged its doctoral program, and attracted 
many promising researchers to Jefferson. 
Friedman is survived by two sons and a 
daughter. 
Fri ends 
It is with sadness we report that two friends 
of Jefferson, Shirley Foerderer Murray and 
Florence deRapalye Foerderer, passed away 
during the fall of 1999. They were two of 
continued on page 25 
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Jefferson Alumni Hall: Faculty Club 
The Philadelphia Club 
Union League of Philadelphia: North Marble Room 
Park Hyatt Philadelphia: Cliveden Room 
The Rittenhouse: Grand Salon 
Pyramid Club: Fairmount Room 
Union League of Philadelphia: Lincoln Lounge and Library 
Park Hyatt Philadelphia: Rose Garden 
Park Hyatt Philadelphia: Conservatory 
Le Colonial 
Jefferson Alumni Hall: Eakins Lounge 
Union League of Philadelphia: McMichael Room 
'40 
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'90 
'95 
60th 
55th 
50th 
45th 
40th 
35th 
30th 
25th 
20th 
15th 
10th 
5th 
Next Association President Ed Jaeger OPH'64 
First Alumni Weekend 
of the Millennium 
June 9, Friday 
Alumni Banquet, at the Union League of Philadelphia, 
with presentation of the Alumni Achievement Awards 
June 10, Saturday 
Women's Forum Breakfast, 
Clinic Presentations, Dean's Luncheon, 
Reunion Class Parties 
The incoming President of 
the Alumni Association is 
well known on campus and 
among the many alumni 
who have been his students. 
Edward A. Jaeger OPH'64 
(pictured on the cover) takes 
office as President at the 
annual business meeting on April 27. 
The warmth of Jaeger's personality is 
familiar to the Alumni Association, to 
which he has given tireless effort over 
the past decade. It's fitting that he is 
the first postgraduate alumnus (who 
Alumni 
Committee, 	
V 10,03 ) . NV.ROV., '57 
 , Imtsliptv ov vilt 
attended a medical school other than 
Jefferson) to be Alumni President, for 	
series Duane's 
in involving 
the postgrad- 
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he has been instrumental, as Chair 
of the Postgraduate 
members of the 
full-fledged 
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uates as 
too, including the 	
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Mail to Alumni Office, 
1020 Locust St. M-41, Phila., PA 19107 
r=I I will attend the Annual Business Meeting & Dinner of 
the JMC Alumni Association on Thursday, April 27, 2000. 
Enclosed is my check for $73.00 (to JMC Alumni Association). 
JI regret that I will be unable to attend. 
He is now a Professor of 
Ophthalmology at Jeff and Director of 
Undergraduate Education in the 
department. This includes instruction 
for all second-year students in the 
Introduction to Clinical Medicine 
course; a clerkship for third-years; 
and contributing to interdepartmental 
inception in 1976. Active in 
numerous local and national organi-
zations, the new alumni leader is a 
past President of the Pennsylvania 
Academy of Ophthalmology. He 
served as a flight surgeon with the 
U.S. Navy Reserve, retiring as a 
Captain in 1986 after 26 years. 4,) 
Name 
    
Jefferson Affiliation 
Address 
Phone 
  
  
  
     
No tickets will be issued. 
offerings for third- and 
fourth-year students. 
The new Alumni President 
practices at Wills Eye 
Hospital, where he's a past 
President of the Medical 
Staff, and Riddle Memorial 
Hospital in Delaware County. Wills 
committees on resident selection, 
credentials, and education have all 
benefited from his participation. 
Dr. Jaeger is Associate Editor of the 
nine-volume, looseleaf textbook 
Jaeger graduated from 
Washington and Jefferson 
College and received his M.D. 
from the University of Pittsburgh. 
has contributed in 	 "CO 	
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Alumni greeted faculty and administrators in Pittsburgh in October. Above, Misty Sloboda, 
Stephen Clute '97, Anastasia Petro '99, Charles Cole '56. At right, Guy Stofman '84 (right) 
with Senior Vice President for Academic Affairs and Dean Joseph S. Gonnella, M.D. 
Alumni Achievement Award: 
The Achievement Award Committee of the alumni association is charged with 
the final selection. Please direct curricula vitae and bibliographies of medical 
college graduates, including postgraduate alumni, whose professional 
activities are sufficiently outstanding to warrant consideration to 
"Attention: Achievement Award Committee," 1020 Locust Street M-41, 
Philadelphia, PA 19107. 
Do You Use Email? 
If you would like to be included in the online alumni email directory, please 
send your name, class, or postgraduate department and email address to 
jmc-alumni.office@mail.tju.edu or use the hyperlink fill out the form on the 
Alumni Office homepage jefflinerju.edu/CWISIJMC/alumni/jmc-alumni.html 
The directory is password-protected and is accessible only to other registered 
JMC alumni, postgraduate alumni, and Alumni Office staff. After we receive 
your information, we will notify you of your user name and password. 
A large turnout welcomed Jefferson leaders to Hershey, Pennsylvania in November. Host 
Raymond C. Grandon '45 is at right. At center are University President Paul C. Brucker, 
M.D. and Senior Vice President for Academic Affairs and Dean Joseph S. Gonnella, M.D. Please Vote for Alumni Trustee—
Use the Reply Card 
between Pages 8 and 9 
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Planning for Your Future with Jefferson 
Charitable Gift Annuity Program 
A charitable gift annuity allows alumni and friends of Jefferson to make a gift 
and retain an attractive rate of income for the lives of one or two beneficiaries. 
Benefits Include: 
• A solid return on your investment 	 • Fixed income for the lives of one 
or two beneficiaries (a portion is tax-free) 
• Current income tax deduction 	 • Low minimum gift of $10,000 per annuity 
Sample Gift Annuity Rates* 
(for $10,000 Charitable Gift Annuity) 
One Life Annuity 
Age 	 Rate 	 Deduction' 
Two Life Annuity 
Ages 	 Rate 	 Deduction** 
50 5.8% $3,410 50/50 5.6% $2,982 
55 6.1% $3,491 55/55 5.8% $3,014 
60 6.6% $3,488 60/60 6.3% $2,806 
65 7.0% $3,728 65/65 6.6% $2,975 
70 7.5% $4,047 70/70 6.8% $3,404 
75 8.2% $4,388 75/75 7.3% $3,720 
80 9.2% $4,770 80/80 8.0% $4,109 
* Higher rates available to age 95 
*" Charitable deduction will vary slightly depending on the timing of the gift, due to fluctuations in the Federal Discount Rate. 
For a personalized charitable gift annuity calculation or more information, 
complete and return the attached postcard 
or call, toll free, Jefferson Trusts and Estates at 1-877-JEFF GIFT (1-877-533-3443). 
You may also email your questions or request for information to jeff.trust@mail.tju.edu 
A Jefferson Planned Gift: An Investment in the Future 
* This advertisement is for illustrative purposes only and is based upon the Federal tax laws in effect on January 4, 2000, and 
should not be construed as tax advice. The laws and regulations of individual states are not discussed. Please note that individual tax circumstances may vary and the 
laws are subject to change. We recommend you consult your own tax advisor before making any financial decisions. 
Foerderer continued from page 21 
the three daughters of the late Percival E. 
and Ethel Brown Foerderer, a couple whose 
extraordinary commitment to Jefferson's 
growth spanned more than 60 years. 
The Foerderer family's generosity has 
helped establish Jefferson as an outstanding 
academic institution, and their support of 
Thomas Jefferson University Hospital has 
helped advance patient care. Percival 
Foerderer, who was elected a trustee of 
Jefferson Medical College in 1928, served as 
Chairman of the Board of Trustees from 
1950 until 1961 and was named a Life 
Trustee. Ethel Foerderer was elected to the 
Women's Board of Thomas Jefferson 
University Hospital in 1930 and served as its 
President from 1947 through 1952. With 
approximately $1 million, they created the 
Foerderer Foundation in 1962 and 
continued a tradition of philanthropy to 
Jefferson. The Foerderer Pavilion was 
named in their honor. 
Florence Foerderer, as a member of the 
Foerderer Foundation's Board of Trustees, 
and Shirley Foerderer Murray, as chair of its 
committee that met annually to determine 
support for Jefferson, continued their 
family's legacy. In 1994, the foundation 
transferred its assets, by then totaling 
$9 million, to Jefferson to endow three 
programs the family had previously 
established. The Martin E. Rehfuss Lecture, 
in memory of the Jefferson Professor of 
Clinical Medicine who was Mr. and Mrs. 
Foerderer's personal physician and friend, 
annually draws an internationally prominent 
scientist or health care expert (see page 16 
about this year's lecturer). The Foerderer 
gift also endowed grants for research and 
the Foerderer Fellowships in the College of 
Graduate Studies (see page 9 about a recent 
recipient). The foundation was honored in 
1981 and 1994 as the recipient of the 
Cornerstone Award of the President's Club, 
an extraordinary honor. 
At the time, this was the largest single gift in 
Jefferson's history and it became the nucleus 
of the university's Foerderer Fund, which 
now totals more than $15 million. Members 
of the Foerderer family and others who were 
trustees of the foundation still meet with 
representatives of the university to 
determine allocation of the funds. 
"Shirley tirelessly gave of herself to Jefferson 
and she will be remembered with great 
appreciation," said Jussi Saukkonen, M.D., 
the University's Vice President for Science 
Policy, Technology Development, and 
International Affairs, and Dean of Graduate 
Studies. "She took a special interest in 
Jefferson, its programs, and its students, and 
I feel very privileged to have enjoyed her 
friendship." 
Ms. Foerderer and Mrs. Murray are survived 
by their sister, Mignon Foerderer Davis. 
Mrs. Murray also is survived by her 
husband, Francis W. Murray III, as well as 
three children and six grandchildren. 
Gifts may be directed to the Foerderer Fund 
in memory of Shirley Foerderer Murray or 
Florence Foerderer, do the Thomas 
Jefferson University Development Office, 
925 Chestnut Street, Suite 110, Philadelphia, 
PA 19107. 
'42 
James A. Heckman recently moved 
into the Woodlands, a retirement 
community in Huntington, WV. He 
retired from his practice of 
orthopaedic surgery in 1985. 
'45 55th Reunion June 10 
Robert C. Puff has moved to a 
"beautiful" new retirement 
community called Devonshire in 
Palm Beach Gardens, FL. 
'52 
Congratulations to Jerome J. Berner 
of Shaker Heights, OH who married 
Jeanne Steinberger in January 1999. 
Edward W. Ditto III of Hagerstown, 
MD has finally retired after 46 years 
of family practice. He is fortunate to 
have all three of his children nearby, 
including Allen W. Ditto '79. 
'53 
To help his community celebrate its 
bicentennial, Robert Poole has 
written The Evolution of Health Care 
in the Community of West Chester, 
Pennsylvania 1799-1999. Dr. Poole is 
a longtime medical and civic leader in 
this town near Philadelphia. 
'54 
Joseph L. Abbott has retired but is 
still volunteering in a free clinic for 
uninsured patients in Chester 
County, PA. 
N. Blaine Groves of Martinsburg, WV 
has earned many recognitions from 
his community: the Distinguished 
West Virginian award from the 
governor and the West Virginia 
University Outstanding Graduate 
award for citizenship and community 
service. The Martinsburg Journal has 
honored him for his citizenship. The 
Eastern Panhandle Training Center 
for the Handicapped has named their 
main building the N. B. Groves Work 
Center, and the Berkeley County 
Board of Education's new meeting 
room has been named the Dr. N. 
Blaine Groves Boardroom. 
Robert A. Hinrichs of Corona Del 
Mar, CA is now retired. He still walks 
18 holes of golf and carries his bag. 
'56 
Paul E. Frank of Meadowbrook, PA 
has retired from practice and stepped 
down as Chief of Ophthalmology at 
Abington Memorial Hospital. 
'57 
Martin G. Blechman of Paramus, NJ 
continues his diabetes practice with 
his wife. They'd like to find a young 
doctor to phase into their practice. 
Donald P. Elliott of Denver, CO 
retired in April 1997 and has made 
several trips to central Asia and India 
with medical teams to perform and 
teach heart surgery. 
'58 
Malcolm L. Cowen of Bethlehem, PA 
retired fully from pathology as of 
September 1999. 
Richard E. Eshbach and wife Lillian 
are enjoying their retirement in the 
"stimulating" country of Greece. 
Marvin Z. Rotman is still Chair of 
Radiation Oncology at the State 
University of New York in Brooklyn. 
He, his wife Marsha, and their four 
children live in Kings Point, NY. 
Robert G. Somers of Elkins Park, PA, 
his daughter Debra Somers Copit '89, 
radiologist, and son-in-law Steven E. 
Copit '88, plastic surgeon, work 
together treating patients battling 
breast cancer. Dr. Somers, a pioneer 
in breast conservation surgery, 
recently received Albert Einstein 
Healthcare's Physician Leadership 
Award. He began Einstein's multidis-
ciplinary breast cancer program 
which has become a model for 
programs around the country. 
'60 40th Reunion June 10 
Harold J. Kobb of Cherry Hill, NJ 
retired in 1997 and is painting, 
teaching art, and traveling. 
'61 
Leon Mironoff recently retired from 
family practice after more than 35 
years in San Clemente, CA. 
'62 
Marvin J. Rapaport of Los Angeles 
and daughter Vickie '98, a 
dermatology resident at Jefferson, 
recently published a paper entitled 
"Eyelid Dermatitis to Red Face 
Syndrome to Cure: Clinical 
Experience in 100 Cases" in the 
Journal of the American Academy of 
Dermatology. They have lectured on 
this subject at several meetings 
around the country. 
Stephen Gosin of Linwood, NJ is 
Chair of Surgery at Shore Memorial 
Hospital in Somers Point and is very 
proud that son Jeffrey S. Gosin '89, 
who is board certified in vascular 
surgery, is now his partner. 
'63 
Paul Rodenhauser, a faculty 
physician and Assistant Dean at 
Tulane University School of Medicine 
in New Orleans since 1991, has been 
a leader in incorporating the creative 
arts into the medical curriculum. He 
is a Professor of Psychiatry and 
Director of Medical Student 
Education in the department. A 
generous endowment at Tulane 
encourages its medical students and 
faculty to be personally involved in 
the creative arts. Dr. Rodenhauser has 
received numerous awards from 
Tulane and from national psychiatry 
organizations, and is an examiner for 
the American Board of Psychiatry and 
Neurology. Creative writing has been 
an enduring interest for Rodenhauser 
since he became a New Orleans 
resident. His poems have appeared in 
The Pharos and The Journal of Poetry 
Therapy. He has published short 
stories and a novella, and a one act 
play of his was produced at the New 
Orleans Contemporary Arts Center 
in 1998. 
Melvin Yudis is now Chief of 
Nephrology at Abington Memorial 
Hospital and was recently designated 
by the American Society of 
Hypertension as a Clinical Specialist 
in Hypertension. He resides in 
Rydal, PA. 
'64 
James C. Barton of Chambersburg, 
PA writes, "One of the rewards of 
family practice is the joy of growing 
old with your patients who become 
your friends, and almost your 
relatives. It becomes harder and 
harder to think of leaving them or 
their leaving you." 
John P. WhitecarJr. and his wife are 
now in their third year of living in 
Columbus, MS, "working hard and 
having fun." 
'65 35th Reunion June 10 
Merle Edelstein has been appointed 
Instructor in Psychiatry and Human 
Behavior at Jefferson. 
Margaret M. Libonati of Philadelphia 
writes that "retirement is an 
unbelievably sweet time" for her and 
her husband. They spend it partly in 
the city and mostly in the country, 
enjoying their gardening. 
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CLASS NOTES 	 Please Suggest Names of 
Young Alumni for Profiles 
Graduates of Jefferson Medical College are scattered across this country and 
abroad practicing exemplary medicine, teaching others, and contributing to 
medicine's expanding knowledge base. The Bulletin would like to identify some 
of the graduates of the classes since 1980 whose activities could be spotlighted 
in coming issues. If you know alumni or postgraduate alumni whose careers fit 
this description, please send 
1) name/class, 
2) short letter outlining career activities, and 
3) current curriculum vitae, to: 
Malcolm Clendenin, Editor, Alumni Bulletin 
1020 Locust Street, Suite M-41 
Philadelphia, PA 19107-6799 
Phone: 215 955 7920 	 Fax: 215 923 9916 
Email: Malcolm.Clendenin®mail.tju.edu 
Antonio Ramos-Umpierre of Dorado, 
PR is proud to note that son Jost is in 
his second year at Jefferson. 
Donald H. Smith has been installed as 
President of the Pennsylvania Medical 
Society. Dr. Smith, a general and 
oncologic surgeon, is used to being at 
the helm. He was the founder and 
President of one of the first physician 
organizations in Pennsylvania, the 
Easton Medical Surgical Association, 
and in 1991 he was a founding 
member and subsequent President of 
the American Society of General 
Surgeons. Dr. Smith and his wife, 
Nancy, live in Eagles Mere, PA and 
have three sons, Gregory, Jeffrey, and 
Eric '00. 
'66 
Andrew L Bender of Westwood, NJ 
has retired from his neuro-oncology 
practice. 
Robert H. Kirschner has retired from 
the Medical Examiner's Office in 
Chicago, but continues to teach at the 
University of Chicago and to partic-
ipate in international human rights 
work. He also does extensive 
lecturing and consulting on child 
abuse cases around the country. His 
niece, Joanna Starrels, is now a 
second year student at JMC. 
'67 
Marc A. Shuman serves as Associate 
Director for Laboratory Research, 
Training, and Education and is 
Program Director for Genito-urinary 
Cancer at UCSF's new National 
Cancer Institute designated cancer 
center, the first in the Bay Area. 
Although he sees patients, research 
continues to be his priority. He is the 
principal investigator on a large 
multidisciplinary NCI grant studying 
proteases in epithelial cancers. 
John S. Wills of Wilmington, DE is 
currently Chair of Radiology at 
Christiana Care Health System. 
'68 
Joel M. Barish of New York City 
plans to retire in 2002 and return to 
California. He is on the faculty of 
Columbia University College of 
Physicians and Surgeons, and in 
September became an Associate Chair 
of Medicine at St. Luke's-Roosevelt 
Hospital Center. 
James B. Turchik of Syracuse, NY 
continues to enjoy teaching at the 
SUNY Health Sciences Center, 
Division of Infectious Diseases. 
'69 
Barry S. Smith of Dallas, TX has 
completed his term as President of 
the American Association of Physical 
Medicine and Rehabilitation and is 
now President of the Association of 
Academic Physiatrists. Barry currently 
is Chief of Physical Medicine and 
Rehabilitation Services for Baylor 
Healthcare Systems in Dallas. 
'70 30th Reunion June 10 
James W. Kendig has joined the 
Section of Newborn Medicine at the 
Milton S. Hershey Medical Center, 
Penn State Geisinger Children's 
Hospital as Professor of Pediatrics. He 
resides in Palmyra, PA. 
Sarah S. Long of Gladw) ne, PA is 
currently President of the Medical 
Staff at St. Christopher's Hospital for 
Children. Daughter Suzanne is 
"forging through her second year at 
JMC, which seems to be no easier or 
less stressful than 30 years ago." 
Lawrence S. Miller of Los Angeles 
reports that daughter Shana is a 
student in the master's degree 
program in physical therapy at 
Jefferson. 
Judith Parker Schwartz and Burton 
W. Schwartz '67 of Fort Worth, TX 
are delighted to note that their son 
Hamilton Schwartz '99 is a pediatrics 
resident at Cincinnati Children's 
Hospital where classmate Michael K. 
Farrell '70 is Residency Director and 
Chief of Staff. 
Paul M. Selinkaor of San Antonio is 
finishing his years as Chief of Staff at 
the biggest hospital in south Texas. 
He recently took in a new partner. 
Calvin L. Weisberger of Santa 
Monica, CA is still the Coordinating 
Chief of Cardiology for the Southern 
California Permanente Medical 
Group. 
'71 
Peter M. Caravello of Johnson City, 
TN is enjoying private practice of 
internal medicine in eastern 
Tennessee. 
Delvyn C. Case Jr. of Cumberland 
Foreside, ME is a senior physician at 
the Maine Center for Cancer 
Medicine and Blood Disorders. He is 
Assistant Director, Division of 
Hematology, Maine Medical Center, 
and Clinical Director of its Bone 
Marrow Transplantation Program. Dr. 
Case is a Clinical Professor at the 
University of Vermont College of 
Medicine. He regularly contributes 
articles on religion and medicine to 
the Portland, ME Press Herald. 
David R. Cooper of Shavertown, PA is 
in his 18th year as orthopaedic 
surgeon to NASCAR at Pocono 
Raceway. A sports enthusiast, he still 
has his original Spectrum usher's 
uniform from 1967 when he worked 
at Philadelphia hockey games while a 
first year medical student. 
Barbara L Tenney, a pediatrician 
living in Pottsville, PA, was elected 
Chair of the Board of Trustees of 
Wilson College in Chambersburg, PA, 
where she received her undergraduate 
education. 
'72 
Carolyn E. Bekes has been appointed 
Executive Vice President for Medical 
Affairs at the Cooper Health System in 
Camden, NJ. 
'74 
Albert L Blumberg, a radiation 
oncologist in Baltimore, is President-
elect of the Maryland State Medical 
Society. 
John J. Brooks Jr. of Orchard Park, 
NY was recently appointed to the 
Medicare Coverage Advisory 
Committee for Pathology and 
Laboratory Diagnostics, the group 
that decides which tests are covered 
by Medicare. 
'75 25th Reunion June 10 
Ellis FL Levin received the 1999 
Athlie Clarke Research Award, the 
highest research honor bestowed by 
the University of California, Irvine 
College of Medicine, where he is Vice 
Chair and Professor of Medicine. 
Michael D. Perilstein of Wyomissing, 
PA has a son, Philip, who is a third 
year medical student at Jefferson. 
'76 
Halley S. Faust, M.P.H. of West 
Hartford, CT has been appointed to 
the Medicare Coverage Advisory 
Committee to evaluate the 
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Bringing Out What's Inside the Patient 
Adapted from an article by Laura Muha in Biography magazine, September 1999 
effectiveness and appropriateness of 
medical services and technologies 
that are, or are proposed to be, 
covered under Medicare. Dr. Faust is 
the manager of Medmax Ventures of 
Bloomfield, a medical technology 
venture capital fund with its primary 
investments in Israel. He is also the 
manager of Jerome Capital, which 
invests in medical services companies 
in the U.S. 
John W. Thompson has accepted a 
position in Titusville, PA doing 
general radiology. He and four 
children survive Diana Garmat 
Thompson (B.S.'75 at Jefferson in 
Medical Technology). 
Barbara L and Stephen K Katz of 
Meadowbrook, PA have left private 
practice pediatrics and are currently 
doing locum tenens. 
'77 
Robert S. Boova, system chief of 
cardiothoracic surgery at Main Line 
Health System (a part of the Jefferson 
Health System), has become very 
experienced in keyhole coronary 
bypass surgery, a method of 
bypassing clogged arteries without 
cracking open the chest. Instead of a 
12- to 16-inch incision down the 
center of the chest, a three-inch hole 
is made, and the surgeon uses long 
instruments to reach between ribs to 
the heart. The scar is tiny compared 
to that left by traditional bypass 
surgery, and recovery averages six 
weeks instead of 12. A heart-lung 
machine takes over blood 
oxygenation and circulation during 
the surgery; the machine connects 
with the body via tubes in an incision 
in the groin. 
Robert C. Savage of Wellesley, MA, 
the immediate past President of the 
New England Society of Plastic and 
Reconstructive Surgeons, is currently 
the Secretary of the Massachusetts 
Society of Plastic Surgeons. 
Paul IL Weber and wife Barbara 
celebrated their anniversary last 
summer by climbing to the summit of 
Mount Whitney (14,496 feet) in 
California. Their home is in Rancho 
Palos Verdes. 
'78 
Neil H. Shusterman of Wynnewood, 
PA continues at SmithKline Beecham 
in Clinical Research and 
Development. He chaired a session at 
the Heart Failure Society of America 
meeting this past September. 
'79 
Jeffrey C. Brandon and Christine 
Evankovich were married on October 
16 in Karns City, PA. Dr. Brandon is 
Vice Chair of Radiology, and Dr. 
Evankovich is a trauma surgeon, at 
the University of South Alabama in 
Mobile. 
'80 20th Reunion Junel 0 
Charles J. Minton has been promoted 
to Professor of Obstetrics and 
Gynecology at Jefferson. He practices 
at Bryn Mawr Hospital. 
Beverly L. Hershey is now a Clinical 
Assistant Professor of Radiology at 
Jefferson, practicing at Methodist 
Hospital. 
Stephen A. Geraci is now an 
Associate Professor of Medicine and 
Cardiology Program Director at the 
University of Florida in Jacksonville, 
and Director of Inpatient Cardiology 
Services at Shands Hospital. 
Angela E. Lin of Westwood, MA 
visited Beijing last spring and gave a 
lecture to the Department of 
Pediatrics at Beijing Medical College. 
Several staff members there were 
collaborators on a recent CDC project 
which looked at the impact of folic 
acid on neural tube defects. 
'81 
"Mitch" Edmondson of Milford, DE 
and wife Loretta joyfully announce 
the adoption of their daughter, Anna 
Lee, from the People's Republic of 
China, at the age of one year. Anna is 
"a happy, healthy child," and her 
parents are "withstanding the rigors 
of new parenthood remarkably well." 
James D. Kolker is now Medical 
Director for radiation oncology at 
East Texas Medical Center in Tyler. 
Samuel S. 'Arras II of Dallastown, 
PA has been elected President of the 
Pennsylvania Society of Colon and 
Rectal Surgeons. 
David C. Slagle has been living in 
Peoria, IL since leaving the U.S. Army 
six years ago. He is Chief of Infectious 
Diseases at the University of Illinois 
College of Medicine, and Medical 
Director of the Heart of Illinois 
HIV/AIDS Center. 
'82 
Robert M. McNamara of Lafayette 
Hill, PA is now Chief of Emergency 
Medicine at Temple University. 
As her 50th birthday approached last year, Marion Lane took a good look 
in the mirror and was dismayed by what 
she saw: wrinkles, a double chin, 
pouches of fat under her eyes. "I hardly 
recognized myself," she recalls. So the 
Chester, Pennsylvania elementary school 
principal did something she never 
thought she'd do: she made an 
appointment with John H. Moore Jr. 
PS'85, a plastic and reconstructive 
surgeon at Jefferson. 
As one of the busiest plastic 
surgeons in the city, Moore 
spends a significant portion of 
his time giving patients like 
Lane the things that nature 
did not: age resistant faces, 
small noses, big breasts, thin 
thighs. "Sometimes, I feel like 
I'm helping to create a whole new human 
being," Moore says, adding that he's not 
referring to the patient's appearance but 
to the psychological changes that often 
go hand-in-hand with the physical ones. 
"When people feel good about the way 
they look, they often find the courage to 
take other, more significant steps in their 
lives," he explains. "It's as though there's 
another person who's been locked inside; 
what the surgery does is help to bring 
them out." 
In Lane's case, Moore recommended not 
the facelift that Lane initially thought she 
needed, but two less expensive 45-
minute outpatient procedures: one to 
liposuction the "wattle" beneath her 
chin, the second to extract fatty tissue 
from under her eyes—the latter being 
performed from the inside of her eyelid 
to prevent scarring. The final step was an 
in-office chemical peel to minimize the 
lines and erase age-related freckling. Lane 
reports that she had almost no pain or 
bruising—and she couldn't be happier 
with the results. "The difference is 
amazing," she says. 
Last year alone, more than one million 
Americans underwent cosmetic 
procedures ranging from hair transplants 
to collagen injections to tummy 
tucks—an increase of 153 percent since 
1992, according to the American Society 
of Plastic and Reconstructive Surgeons. 
The job actually has a decidedly gritty 
side. The specialty was born during the 
Spanish-American and Crimean wars, as 
surgeons found ways to rebuild the shot-
off faces of soldiers; afterward, they 
found enterprising peacetime ways to 
apply what they'd learned. "A facelift is 
nothing more than a modification of a 
standard technique for facial 
reconstruction," says Moore, adding that 
even today, the majority of plastic 
surgeons do a significant amount of 
reconstructive work. 
It's not unusual for Moore to be called 
out of bed in the middle of the night to 
repair the face of an accident victim; 
he's also one of Philadelphia's most 
sought-after surgeons for post-
mastectomy breast reconstruction. And 
while most plastic surgeons phase out 
reconstructive work in favor of cosmetic 
surgery as their careers advance—with 
the latter, they can set their own hours 
and, since patients pay out of pocket, 
I avoid insurance hassles—
Moore has no plans to do so. 
"I like dealing with breast 
cancer patients; it's 
challenging, and I think it 
helps keep you grounded." 
With his laid-back demeanor 
and irreverent sense of 
humor, Moore, 46, is on a 
first-name basis with many of his 
patients, bantering with them about 
their jobs, their love lives, the trials of 
living with teenagers. (Moore should 
know: he has three, plus a preteen.) 
A significant amount of Moore's time is 
also spent educating patients about the 
seriousness of plastic surgery. "Yes, 
you're tuning somebody up, making 
them look better," he says, "but it's still 
surgery, and you do see complications 
[with] wound healing, scarring, 
anesthesia. Not often, but it does 
happen." 
By the end of a long day in the office, 
he will have consulted with more than 
30 patients. 
Moore, an only child, grew up in 
Lancaster, Pennsylvania, and knew by 
the time he was four that he wanted to 
become a doctor. As an undergraduate, 
he attended the University of Virginia, 
where he combined classes in biology, 
psychology, and sociology to create a 
special major he called Human 
Development; after graduation, he 
stayed on at the university for medical 
school, followed by residency at 
Jefferson. Initially, he planned to be a 
family practitioner but changed his mind 
after taking a rotation in plastic surgery. 
"It just clicked," he says of the specialty. 
Even though he's a self-described 
workaholic, Moore rarely misses any of 
his children's activities, cheering them 
on at hockey games and rowing meets. 
In what little spare time is left over, he 
likes "trying to hit golf balls," as he puts 
it, and every other year he donates 
nearly a month of his time to Operation 
Smile, a nonprofit group that sends 
plastic surgeons to Third World 
countries to repair birth defects in 
children. "It brings back the reason you 
went into medicine—to help people," 
he says. 
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Jeff in the 50th State 
In January at the Oahu Country Club, Hawaii alumni greeted Tom Nasca '75 
(back row, fourth from left), 
Associate Dean for Academic 
Affairs and Affiliations, and 
Frederick "Fritz" Ruccius 
(back row, second from right), 
Director of Development for 
Trusts and Estates. At right, 
Dr. Nasca and Robert Atkinson 
'77, Alumni Vice President for 
Hawaii. 
CLASS NOTES Read the Bulletin on the Net 
Point your browser to jeffline.tju.edu/CWIS4MC/alumni/bulletin.html 
to read this magazine online. The website now offers you a choice of 
HTML ("traditional" web pages) or 
'83 
Peter A. Cognetti of Waverly, PA has 
been elected Chairman of the Board 
of Heritage Alliance Primary Care, an 
independent practice association. 
'84 
John F. Cox of Bethlehem, PA and 
wife Carol now have two sons, Jason 
and Stephen. "Never a dull moment!" 
Mary B. White announces the birth of 
her first child, Lucia Martinez White, 
on July 17, 1999. Mary is on the 
internal medicine faculty at the West 
Los Angeles VA Medical Center. 
'86 
Michael T. Brown was appointed 
liaison physician for Reading Hospital 
and Medical Center to the 
Commission on Cancer of the 
American College of Physicians. 
Dr. Brown lives in the Reading, PA 
area with wife Patti Jo Brown and 
their four children. 
JoAnne K. Wills is happily practicing 
family medicine in Baltimore. She and 
her husband, Capt. Richard Holzman, 
welcomed their second child, Joseph, 
who joins older sister Margaret. 
'87 
Gregory C. Kane has been promoted 
to Clinical Associate Professor of 
Medicine at Jefferson. 
R. Michael Siatkowski and wife Rhea 
joined the faculty of the Dean McGee 
Eye Institute at the University of 
Oklahoma in Oklahoma City this 
year. They "have been tremendously 
blessed after our first year of 
marriage." 
'88 
Ann G. Auletta and Richard K. 
Sterling of Richard, VA are thrilled to 
announce the birth of Joseph Andrew 
Sterling in September 1999. Ann is an 
emergency room/trauma radiologist at 
the Medical College of Virginia 
Hospitals, where Richard is the 
Assistant Medical Director of Liver 
Transplantation. 
John W. Reynolds and his wife, Argilla 
George, M.D., have started a private 
family practice in Hinesburg, VT. 
'89 
William V. Harrer was recently 
promoted to Director of Medical 
Oncology at the Lewis Hall Singletary 
Oncology Center in Thomasville, GA. 
Kathleen M. Palmer of Wallingford, 
PA gave birth to a baby girl, Ellen 
Therese Kerns, on October 19. 
Jonathan Pontell completed his 
military obligation in Hawaii, and 
with wife Bonnie has returned home 
to the Delaware Valley and the 
Jefferson Health System to start a new 
practice called Delaware Valley Facial 
Plastic Surgery, with offices in 
Wynnewood and Paoli, PA and 
Wilmington, DE. 
Christopher T. Siegel received his 
Ph.D. in Immunology from the 
University of Chicago in August 1999 
where he also completed a fellowship 
in transplantation surgery. He is 
currently on the staff of the 
University Hospitals of Cleveland for 
both general surgery and abdominal 
organ transplantation. He holds a 
faculty appointment as Assistant 
Professor at Case Western Reserve 
University's School of Medicine. His 
research laboratory focuses on 
molecular and animal models of 
hepatocellular carcinoma and cellular 
transplantation. 
Lisa Verno Turner completed her Air 
Force commitment as Chief of 
Pediatrics at Grand Forks Air Force 
Base, ND. She is currently a 
hospitalist in the Department of 
Pediatrics at St. Joseph Mercy 
Hospital, and a Clinical Instructor of 
Pediatrics at the University of 
Michigan Medical School in 
Ann Arbor. 
'91 
Mitchell I. Edelson and Michelle D. 
Vichnin welcome their new daughter 
Jessica Rose Edelson, born August 11. 
Mitch completed his fellowship in 
gynecologic oncology at Brigham and 
Women's Hospital/Harvard Medical 
School, and is now in practice at the 
Reading Hospital in Reading, PA. 
Michelle completed her residency in 
obstetrics and gynecology at the New 
York Hospital/Cornell University 
Medical Center, and is in private 
practice at the Reading Hospital as 
well. 
'92 
Joseph E. August of Stoneham, MA is 
practicing internal medicine at Salem 
Hospital. He and wife Kathleen have 
four children. 
Michael A. Gold completed a 
fellowship in gynecologic oncology 
at the University of Oklahoma last 
June. In April 1999, he married 
Karen Marie Pearce, who is an 
obstetrician-gynecologist and a 
Captain in the Air Force. Karen is 
stationed at Sheppard Air Force Base 
in Wichita Falls, TX where they live 
with their two daughters, Morgan 
and Ariel. 
James J. McKeith of Glen Allen, VA 
is an Assistant Professor of 
Emergency Medicine, and Director of 
Quality at the Medical College of 
Virginia Hospitals. He and wife 
Crista have a daughter and a son. 
Norman L. Sykes Jr. is now a Clinical 
Assistant Professor of Dermatology 
and Cutaneous Biology at Jefferson. 
'93 
Pamela A. Atkinson recently married 
William Polise. She has accepted a 
position as Instructor of 
Anesthesiology at Jefferson. Her 
subspecialty areas include obstetrical 
and neurosurgical anesthesia. 
Eileen R. Conti is in private practice 
of internal medicine in New Jersey. 
Jane J. Hughes and Kurt M. Heil '95 
are proud to announce the birth of 
second son Ryan James Heil on 
November 16. They reside in 
Wexford, PA. 
PDF—Adobe's Acrobat format, which looks on your screen exactly like the 
print version. The Bulletin website helps you download a free Acrobat Reader if 
you don't already have it. Acrobat gives you cool features including search 
capability. Back issues are there too. It's easy! 
The Bulletin homepage also includes a form for submitting news or 
Class Notes online. 
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Jeffersonians Lead in the AMA 
Five '62 classmates at the San Diego reception: Jim Marvel, 
Joe Snyder, Bill Harrer, Joe Sokolowski (all AMA Delegates), 
and Michael 
Prendergast. In 
addition, no fewer 
than five Jefferson 
students went 
to San Diego for 
the AMA meeting, 
where they 
participated in the 
student section. 
Other Jeffersonians are active in the association too, such as Victor Greco '51 
who currently chairs the Pennsylvania delegation to the AMA. 
Two AMA Trustees, 
William Mahood '60 
and Joseph Riggs 
OBG'64 (at right), 
joined Simon 
Brumbaugh Jr. '51 
(Alumni Vice 
President for San 
Diego) at a Jefferson 
reception at the 
American Medical 
Association meeting 
in San Diego in 
December. 
Leslie Magalong and Matt Killion 
were married November 13 in 
Wilmington, DE. The wedding party 
included maid of honor Lynn Yang 
'95, bridesmaid Liza De Annuntis 
'93, and groomsmen John Butler '93 
and Jamie Hey '93. Also attending 
were Alan Reinach '93, David Litt 
'93, and John Caruso '91. Leslie is 
now in private practice of internal 
medicine at Crozer-Chester Medical 
Center. Matt stayed at Jefferson where 
he was Chief Medical Resident along 
with Jamie Hey and Alan Reinach 
who are finishing pulmonary/critical 
care fellowships at Yale and Jefferson, 
respectively. Matt is now an Assistant 
Professor of Medicine at Jeff. 
Scott A. Rushton of Drexel Hill, PA 
has joined the Department of 
Orthopaedic Surgery at the University 
of Pennsylvania and the faculty 
practice of the Penn Orthopaedic 
Institute. He specializes in complex 
spine surgery. 
'94 
On October 16, 1999 Jeffrey Chao 
and Cynthia S. Lin '95 were married. 
They are both in practice in San 
Diego, Cynthia in internal medicine, 
and Jeffrey in occupational 
psychiatry. Jeffrey is also involved in 
part time research at the University of 
California, San Diego. 
Cynthia Cheng has received a 
Jefferson faculty appointment as an 
Instructor in Family Medicine, and 
John J. Park has been appointed an 
Instructor in Anesthesiology. 
Vidu Garg is completing his final year 
of a pediatric cardiology fellowship at 
the University of Texas Southwestern 
Medical Center at Dallas. 
Jeanne M. Lasota and Martin J. 
Vinca have a son, Matthew. Martin 
completed his residency in general 
surgery at Broke Army Medical 
Center this past June and is currently 
on a six month tour of duty in Bosnia. 
'95 Fifth Reunion June 10 
JulieAnne Hlavac Bruno and husband 
Joseph of Dover, DE happily 
announce the birth of their second 
child, Sabrina Elizabeth. 
William P. Charlton was recently 
appointed a Clinical Instructor of 
Orthopaedic Surgery at Jefferson. 
Minetta C. Liu of Arlington, VA is a 
second year fellow in hematology/ 
oncology at Georgetown University 
Medical Center. 
Allen J. Orehek of Honesdale, PA and 
his extended family recently held a 
groundbreaking ceremony for the 
construction of his new medical 
office. Allen is an internist and 
pediatrician. 
'96 
Ryan P. Gallivan is in his fourth year 
of an ear/nose/throat residency at UC 
Irvine. He and his wife Lauren live in 
Santa Ana, CA and have two children, 
Lauren Elizabeth and Aiden. 
'97 
Thomas G. Greidanus of Fort Carson, 
CO is currently a Brigade Surgeon of 
the Fourth Infantry Division, Third 
Brigade Combat Team. He previously 
served in Korea and Hawaii. He and 
his wife Yvonne have two children, 
Christopher and Jardyn (who was 
born in November). 
Lesley James is delighted to announce 
her marriage to Seenu Kaza, M.D. 
Lesley is in her third year of obstetrics 
and gynecology residency at Jefferson. 
Mira Kautzky of Boston married 
Keith Flaherty, M.D. this past fall. 
They are both finishing their internal 
medicine residencies this year and 
plan to move back to Philadelphia. 
'98 
Matthew J. Watson of Danville, PA 
was elected Vice Speaker of the 
Council for the Emergency Medicine 
Residents Association at their 
national meeting in Boston last May. 
He and his wife, Christine, had their 
second child, Sydney Christine, in 
April 1999. Owen Matthew was born 
in April 1997. 
Postgraduate Alumni 
Gary Shaber R'66 has been appointed 
a Research Assistant Professor of 
Radiology at Jefferson. 
Joseph A. Ritsick PM'74 has been 
appointed Medical Director of 
Rehabilitation Services at NorthBay 
Health Care in Fairfield and Vacaville, 
CA. He previously worked in Denver. 
He is a diplomate in pain 
management. 
Albert L. Pizzica PD'78 of Wayne, PA 
has been appointed Medical Director 
of Neonatology at Chestnut Hill 
Hospital, an educational affiliate of 
the University of Pennsylvania. He 
previously had been Director of 
Neonatology and Pediatrics at 
Episcopal Hospital. 
Fred W. Markham Jr. FP'79 has been 
promoted to Clinical Associate 
Professor of Family Medicine at 
Jefferson. 
Janet F. Haas PM'80 has been part of 
the 130-person transition team for 
Philadelphia's new mayor, John F. 
Street. Dr. Haas, who is President of 
the William Penn Foundation, a 
major Philadelphia philanthropy, was 
one of the six cochairs of the 
government organization committee. 
Mahroo Haghbin R0'84 has been 
appointed a Clinical Associate 
Professor of Radiation Oncology at 
Jefferson, and Merrill J. Solan R0'86 
of Media, PA has been appointed an 
Assistant Professor in the department. 
Peter F. Sharkey ORS'90 has been 
promoted to Associate Professor of 
Orthopaedic Surgery at Jefferson, 
Kenneth N. Panitch FP'95 has been 
appointed an Instructor in Family 
Medicine, Frank V. Bearden HO'96 
has been appointed an Instructor in 
Medicine, and Christalene L. 
Saldanha AN'97 has been appointed 
a Clinical Assistant Professor of 
Anesthesiology. 
Kimberly Heath IM'97 has joined the 
Community Memorial Healthcenter 
in South Hill, VA where she resides 
with husband Larry W. Thompson Jr. 
'95, obstetrician and gynecologist, 
who also recently joined the medical 
staff of CMH. 
Bryan O'Neill PM'97 has been 
promoted to Medical Director of the 
Comprehensive Acute Rehabilitation 
Unit of the Jefferson Faculty 
Foundation. Dr. O'Neill as been on 
the faculty at Jefferson since 1997. He 
finished his year as Chief Resident in 
1996, and subsequently completed a 
fellowship in the Neurology 
Department in electroneuromyog-
raphy. Bryan remains active in the 
acute stroke consultation service. His 
expertise includes EMG guided Botox 
injections for spasticity and disorders 
of muscle tone. 
Four new postgraduate alumni have 
received faculty appointments as 
Instructor at Jefferson: Joshua H. 
Barash FP'99 and Susan M. Parks 
FPG'99 in Family Medicine, Robert 
E. Morales NRD'99 in Radiology, and 
Eric L. Gressen R0'99 in Radiation 
Oncology. 
Rosemary L. Giacobbe PD'99 has 
joined Broomall Pediatrics. This 
practice, which is part of Great Valley 
Health of the Jefferson Health System, 
also includes Joseph Becker PD'84 
and Halette Lasker Anderson '85. 
Rosemary completed her Jefferson 
internship and residency in allergy 
and immunology and adolescent 
medicine. 
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California 
Univ. CA-Irvine Medical Center - Irvine 
Ashish Kumar Wadhwa (General Surgery) 
St. Mary's Medical Center - Long Beach 
Sophia Wamsley, MPH (Internal Medicine) 
Cedars-Sinai Medical Center - Los Angeles 
Anne Elizabeth Riffle (Pediatrics) 
Children's Hospital - Los Angeles 
Ara Balkian (Pediatrics) 
University of Southern California — Los 
Angeles 
Milana Vera Dolezal (Internal Medicine) 
Jason Thomas Huffman (Orthopaedics) 
Children's Hospital - Oakland 
Sareena Jaspal (Pediatrics) 
Univ. of CA-Davis Medical Center—
Sacramento 
John Thomas Gallen (Internal Medicine) 
Michael Louis Salamon (Orthopaedics) 
San Diego Naval Medical Center 
Clare Elizabeth Feigl (Transitional) 
Samantha Grillo (General Surgery) 
Francis X. Hall (Internal Medicine) 
Sean Patrick O'Brien (Transitional) 
Univ. of CA-San Diego Medical Center 
Scott Taber Ball (Orthopaedic Surgery) 
Michael William Fitzgerald (Psychiatry) 
Anna Louise Kvasnicka (Family Practice) 
Univ. of CA-San Francisco 
Jason Garrett Krupnick, Ph.D. (Pediatrics) 
Harbor-UCLA Medical Center — Torrance 
Sonya Alene Lewis (Psychiatry) 
Colorado 
Columbia Presbyterian - Denver 
Carolyn Ann Cutney (Transitional) 
Connecticut 
Univ. of Connecticut Hospital -
Farmington 
Laura N. Modzelewski (Emergency 
Medicine) 
Yale-New Haven Hospital - New Haven 
Heather Louise Focht (Internal Medicine) 
Steven Makoto Kodama (Emergency 
Medicine) 
St. Mary's Hospital - Waterbury 
Timothy J. Riley Jr. (General Surgery) 
Delaware 
Christiana Care - Newark 
Michael A. Barkasy Jr. (Family Practice) 
Michael A. Cosgrove (General Surgery) 
Anh Quang Dam (Diagnostic Radiology) 
Hung Quang Dam (Transitional) 
Daniel N. Duran (Family Practice) 
Linda R. Gillespie (Internal Medicine) 
Stephanie A. Lee (Internal Medicine) 
Maria C. Mancuso (Family Practice) 
Michael E. Metzger (Internal Medicine) 
Eric M. Orndorff (Internal Medicine) 
Rosemarie C.Villamayor (Family Practice) 
Heather M. Zinella (Family Practice) 
District of Columbia 
George Washington Univ. Hospital -
Washington 
James Malcolm Borthwick (Psychiatry) 
National Capital Consortium -
Washington 
Louis M. Giangiulio (Pediatrics) 
Patricia G. Stewart (Psychiatry) 
Washington Hospital Center - Washington 
Ira David Kombluth (Internal Medicine) 
Florida 
Jackson Memorial Medical Center - Miami 
Julia Lynn Belkowitz (Pediatrics) 
Florida Hospital — Orlando 
Kelly Roberts (Family Practice) 
Orlando Regional Medical Center - 
Orlando 
Amanpreet Singh Bhullar 
(Obstetrics/Gynecology) 
Bayfrunt Medical Center - St. Petersburg 
Lisa Marie Phelps (Family Practice) 
Georgia 
Medical College of Georgia - Augusta 
Steven Barry Holsten Jr. (General Surgery) 
Idaho 
Family Practice Medical Center - Boise 
Timothy C. Malyk (Family Practice) 
Illinois 
Rush/Presbyterian/St. Luke's Hosp. -
Chicago 
Renee Ann Ellis (Internal Medicine) 
Dana Ann Obzut (Pediatrics) 
Kern Singh (Orthopaedic Surgery) 
Univ. of Chicago Hospital — Chicago 
Christopher Chiang (Neurological Surgery) 
Philip Milton Ginsburg (Internal Medicine) 
Louisiana 
Tulane Univ. School of Med. - New Orleans 
Meredith Ann Warner (Orthopaedic 
Surgery) 
Maine 
Central Maine Medical Center - Lewiston 
Karen Kazem Emery (Pediatrics) 
Maryland 
Franklin Square Hospital - Baltimore 
Shenna Renee Keene (Family Practice) 
The Johns Hopkins Hospital - Baltimore 
Matthew Francis Grady (Pediatrics) 
The Johns Hopkins Univ./Sinai Hospital of 
Baltimore 
Karen Lisa Babitt (Internal Medicine) 
Univ. of Maryland Medical System -
Baltimore 
Christopher Michael Lutcavage (General 
Surgery) 
Nirav K. Shah (General Surgery) 
Union Memorial Hospital - Baltimore 
Susan J. Pak (General Surgery) 
Jonathan Frederick Rosenfeld (Orthopaedic 
Surgery) 
Naval Medical Center - Bethesda 
Jennifer Laura Marte (Internal Medicine) 
Massachusetts 
Boston Univ. Medical Center - Boston 
Linda Marie Fedus (Internal Medicine) 
Eugene C. Lam (Internal Medicine) 
Massachusetts General Hospital - Boston 
Benjamin Inbeh Chung (General Surgery) 
Michigan 
St. Joseph Hospital - Ann Arbor 
Peter Chi-Yue Liang (Internal Medicine) 
Univ. of Michigan Hospitals — Ann Arbor 
Ian Alexander S. Smith (Internal Medicine) 
Henry Ford Health Science Center -
Detroit 
Jeffrey M. Sparkman (Emergency 
Medicine) 
McLaren Regional Medical Center—Flint 
Imran A. Khan (Orthopaedics) 
Missouri 
Barnes-Jewish Hospital - St. Louis 
Benjamin Lashar Hoch (Pathology) 
Aruna Krishnan (Internal Medicine) 
Nevada 
Univ. of Nevada School of Medicine - Reno 
Richard Robert Gasparre (Family Practice) 
New Jersey 
UMDNJ-RW Johnson Medical School -
Camden 
Evelyn Kemi Balogun (Internal Medicine) 
Margaret Mary Franger (Internal Medicine) 
Lisa Mackowiak (Emergency Medicine) 
Hunterdon Medical Center - Flemington 
My Gia Nguyen (Family Practice) 
UMDNJ-New Jersey Medical School -
Newark 
Varsha Ghayal (Pediatrics) 
UMDNJ-RW Johnson Medical School -
Piscataway 
John A. Billon (Family Practice) 
Demian Elder (Internal Medicine) 
John B. Maggioncalda (General Surgery) 
Masako Ueda (Internal Medicine) 
Overlook Hospital - Summit 
Alexa R. Raymond (Family Practice) 
West Jersey Health System - Voorhees 
Lucinda Fisher Swartz (Family Pracitice) 
New Mexico 
Univ. of New Mexico Sch. of Medicine -
Albuquerque 
Klarissa Nelson Beller (Internal Medicine) 
New York 
Albert Einstein College of Medicine -
Bronx 
Eric Jay Bergson (General Surgery) 
Beth Israel Medical Center - New York 
Lena Marilyn Bretous (Family Practice) 
Lenox Hill Hospital — New York 
Scott Edmund Jensen (General Surgery) 
Mt. Sinai Hospital — New York 
Asit K. Shah, Ph.D. (Orthopaedic Surgery) 
New York Presbyterian Hospital — New 
York 
Oscar Baylin Goodman Jr., Ph.D. (Internal 
Medicine) 
Kristine Lynn Profeta (General Surgery) 
North Carolina 
Univ. of North Carolina Hospital - Chapel 
Hill 
Christopher Todd Oswald (Internal 
Medicine) 
Niccole Mambu Oswald (Family Practice) 
Univ. Health System East Carolina -
Greenville 
Scott M. Blore (Family Practice) 
John R. Pender IV (General Surgery) 
Wake Forest University Baptist Medical 
Center — Winston-Salem 
Joseph A. Manfredi (Internal Medicine) 
Alissa M. Poppiti (Family Practice) 
Ohio 
Cleveland Clinic Foundation - Cleveland 
Susan Elizabeth Porter (Pathology) 
Conrad Hans Simpfendorfer (General 
Surgery) 
Miami Valley Hospital - Dayton 
Damian M. Andrisani (Orthopaedic 
Surgery) 
University Hospital - Cincinnati 
Hamilton P. Schwartz (Pediatrics) 
U.S. Air Force Medical Center -
Wright-Patterson Air Force Base 
Kevin Walker Johnson (Pediatrics) 
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Pennsylvania 
Abington Memorial Hospital - Abington 
Sangita K. Doshi (Family Practice) 
Jennifer Ann Hager (Family Practice) 
Anudeep Kaur Rahil (Internal Medicine) 
Glenn David Rosen (Family Practice) 
Julia Christine Witmer (Family Practice) 
Jon Charles Yeargan (Family Practice) 
Btyn Mawr Hospital - Bryn Mawr 
Andrew Chuing Liang Chi (Family 
Practice) 
Daniel Paulmier Hepburn (Family Practice) 
Dennis Michael McGorry Jr. (Family 
Practice) 
Paul Punzalan Villasenor (Family Practice) 
Penn State Geisinger Health System -
Danville 
Linnane Rene Batzel (Emergency 
Medicine) 
Gregory Lee Shangold (Emergency 
Medicine) 
Timothy Farrington Wetherill (General 
Surgery) 
Penn State Geisinger Health System -
Hershey 
Nyen Vui Chong (General Surgery) 
Anand V. Germanwala (Orthopaedic 
Surgery) 
Pinnacle Health System - Harrisburg 
John Benson Welch (Family Practice) 
Wyoming Valley Health Care System -
Kingston 
Quentin R. Dolphin (Family Practice) 
Lancaster General Hospital - Lancaster 
Donna Cohen (Family Practice) 
Anne-Marie Derrico (Family Practice) 
Thomas Christopher Scott (Family 
Practice) 
Latrobe Area Hospital - Latrobe 
Kenneth Robert McElynn (Family Practice) 
Albert Einstein Medical Center -
Philadelphia 
Laurie Ann Beilstein (Transitional) 
Jeremy Seth Grayson (Internal Medicine) 
Brian Lester Shrager (General Surgery) 
Rahel Zubairi (Medicine/Pediatrics) 
Chestnut Hill Hospital - Philadelphia 
Steven Robert Sarkisian Jr. (Transitional) 
Children's Hospital — Philadelphia 
Tandy Aye (Pediatrics) 
Sarah Cullen McBride (Pediatrics) 
Joshua Warren Salvin (Pediatrics) 
Frankford Hospital (Torresdale) -
Philadelphia 
Paul E. Fenn Jr. (Transitional) 
Hosp. of the Univ. of Penna. - Philadelphia 
Lara Gayle Chepenik, Ph.D. (Psychiatry) 
Andrew Robert Haas, Ph.D. (Internal 
Medicine) 
Trang Mai Pham (Family Practice) 
Lawrence David Ward (Internal Medicine) 
Constance Miao-Leng Yuan, Ph.D. 
(Pathology) 
Pennsylvania Hospital - Philadelphia 
Mark Fong Chang (General Surgery) 
Carrie Ann Rishko Cusack (Internal 
Medicine) 
Jessica D. Grossman 
(Obstetrics/Gynecology) 
David Miller Heydt (General Surgery) 
Michele Saint Fran Lo 
(Obstetrics/Gynecology) 
St. Christopher's Hospital for Children 
Philadelphia 
Camille Manyan Fung (Pediatrics) 
Candace Ann Tesch (Pediatrics) 
TJU/duPont Children's Hosp. -
Philadelphia 
Linda Cobb Barkasy (Pediatrics) 
Reza James Daugherty (Pediatrics) 
Pia Boben Fenimore (Pediatrics) 
Mara Becker Gottlieb (Pediatrics) 
Renee Elizabeth Riddle (Pediatrics) 
Roslyn J. Thomas (Pediatrics) 
Temple University Hospital - Philadelphia 
Rozy J. Desai (Internal Medicine) 
Thomas Jefferson University Hospital -
Philadelphia 
Bryan Thomas Ambro (General Surgery) 
Alynn C. Bosshard 
(Obstetrics/Gynecology) 
Elaine Yat-Line Chiang (Internal Medicine) 
Daphne J. DeMetry (General Surgery) 
Joshua Aaron Eisenberg (General Surgery) 
Matthew John Fagan 
(Obstetrics/Gynecology) 
Mark Christopher Fletcher (General 
Surgery) 
Laura Beth Frank (Emergency Medicine) 
Walter William Frueh (Orthopaedic 
Surgery) 
Cristopher Jon Garlitz (General Surgery) 
Christopher Andrew Haines (Family 
Practice) 
Stephanie Ann Houser (General Surgery) 
Joshua Maier Hurwitz 
(Obstetrics/Gynecology) 
Jay Stuart Jenoff (Internal Medicine) 
Sungchun Lee (Internal Medicine) 
Elizabeth Bahiya Louka 
(Obstetrics/Gynecology) 
Stephen Carl Chirackal Mathai (Internal 
Medicine) 
Meredith Christine McCormack (Internal 
Medicine) 
Philip Aldo Minotti Jr. (Orthopaedic 
Surgery) 
Sonny Van Nguyen (Internal Medicine) 
Julie Helen Prosseda (Family Practice) 
Phillip R. Reeves (Psychiatry) 
Francis Ernest Rosato Jr. (General Surgery) 
Cathryn Elizabett Savoca (Family Practice) 
Dawn Leigh Swarm (Orthopaedic Surgery) 
Satish Reddy Tiyyagura (Internal 
Medicine) 
Marsha Nicole Wittink (Family Practice) 
University Health Center — Pittsburgh 
Ericka L. Fink (Pediatrics) 
Anastasia Petro (Internal Medicine) 
Univ. of Penna. Health 
System/Presbyterian Hospital -
Philadelphia 
Carolyn Beth Glazer (Transitional) 
Paul James Tapino (Transitional) 
Steven Craig Wagner (Transitional) 
Allegheny University Hospitals -
Pittsburgh 
Saif Uddin Syed (Dermatology) 
Mercy Hospital - Pittsburgh 
Peggy Lin (Pediatrics) 
Western Pennsylvania Hosp. - Pittsburgh 
Michelle Lynne Pohland (Transitional) 
Crater-Chester Medical Center - Upland 
Tricia Lynn Lennox (Transitional) 
Heather Anne Maust (Transitional) 
Gautam Mishra (Transitional) 
Renee L. Oberlander (Family Practice) 
Daniel Adam Shoemaker (Pediatrics) 
Washington Hospital - Washington 
Daniel Scott Martin (Family Practice) 
Lankenau Hospital - Wynnewood 
Martamarie Byron (Internal Medicine) 
Lori Jane Gilbert (Internal Medicine) 
Melodie Trinidad Icasiano 
(Obstetrics/Gynecology) 
Erin C. Langan (Obstetrics/Gynecology) 
Nabile Muhammad Safdar (Internal 
Medicine) 
Javwaud Ahmad Zafar (Internal Medicine) 
Rhode Island 
Memorial Hospital - Pawtucket 
Jennifer Joy Raney (Family Practice) 
Brown Univ. Internal Medical Residency -
Providence 
David Samuel Fefferman (Internal 
Medicine) 
Charles J. Lee (Internal Medicine) 
Rhode Island Hospital/Brown University -
Providence 
Virginia Ravenscroft Smith (Internal 
Medicine) 
South Carolina 
Med. Univ. of South Carolina - Charleston 
Maricelina Doreley Caro (Family Practice) 
Tara Nicole Vandegrift (Family Practice) 
Palmetto Richland Mem. Hosp. - Columbia 
Scott Erik Wagner (Emergency Medicine) 
Greenville Hospital System - Greenville 
Kevin Michael Gilroy (Internal Medicine) 
Ralph Robert Rohatsch III (Transitional) 
Texas 
Baylor College of Medicine - Houston 
Francis Joseph Welsh (General Surgery) 
Vermont 
Univ. of Vermont/Fletcher Allen -
Burlington 
Matthew Benjamin Zavod (General 
Surgery) 
Virginia 
University of Virginia Hospital -
Charlottesville 
Alix Odile Faust (Pediatrics) 
Eastern Virginia Medical Sch. - Norfolk 
RaeAnn Denise Hamilton (Emergency 
Medicine) 
Giniene Margaret Pirkle 
(Obstetrics/Gynecology) 
Medical College of Virginia - Richmond 
Henry H. Chang (Internal Medicine) 
Harley J. Cohen (Internal Medicine) 
Washington 
Madigan Army Medical Center - Tacoma 
Joseph Patrick Brooks (Transitional) 
Robert Wallase Chalmers IV 
(Obstetrics/Gynecology) 
Robert Franklin Crowe (Pediatrics) 
John James McGuigan (Orthopaedic 
Surgery) 
Residency Deferred 
Rebecca Simons 
Mondira Kundu 
May 17, Wednesday 
The 29th annual Raft Debate, organized by the Hobart Amory Hare student society 
7:30-9:30 P.M., Jefferson Alumni Hall cafeteria 
Moderator: Wolfgang Vogel, Ph.D., Pharmacology 
Devil s Advocate: Timothy Babinchak, M.D., Infectious Diseases 
Contestants: David Paskin '64, Surgery 
Carmen Sultana OBG'90, Obstetrics and Gynecology 
Charles Pohl '87, Pediatrics 
May 18, Thursday 
Alumni reception with Dean and Senior Vice President for Academic Affairs 
Joseph S. Gonnella, M.D., at the Brown Palace Hotel, Denver 
May 20-21 
CME program at Jefferson on botanical medicine with Simon Mills (see page 6) 
May 21, Sunday 
Alumni reception at the meeting of the American College of Obstetricians and Gynecologists, 
San Francisco 
Alumni Weekend (see page 22) 
June 9, Friday, alumni banquet 
June 10, Saturday, clinic presentations, reunion parties 
June 13, Tuesday 
Spinal Cord Injury Center benefit with Christopher Reeve at the Four Seasons Hotel, 
Philadelphia 
June 27—July 1 
Computers in Health Care Education Symposium, in Salt Lake City, Utah, 
cosponsored by Thomas Jefferson University and the Health Sciences Libraries Consortium 
(for more information: Rodney.B.Murray@mail.tju.edu) 
October 27, 2000 
President's Club Dinner at the Ritz-Carlton Hotel, Philadelphia 
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